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ABSTRACT 
 
The nuclear lamina (NL) is a fibrillary protein network lining the inner surface of the nuclear 
envelope. It is mainly composed by type V intermediate filaments called lamins and lamin-associated 
proteins. Three lamin genes are present in Mammals: LMNA, which encodes lamin A and lamin C (A-
type lamins), as well as, LMNB1 and LMNB2 that encode lamin B1 and B2 (B-type lamins) 
respectively. Lamins and LAPs associate to form a dense and dynamic three-dimensional matrix that 
establishes a huge number of stable and transient interactions with different classes of molecules: 
DNA, transcription factors, nuclear pore complexes and structural proteins of the cytoskeleton. All of 
these interactions are essential to provide nuclear structural stability and integrity, to physically and 
functionally link nuclear lamina to the cytoskeleton and to organizes chromatin. Thus NL, in 
addition to play a fundamental structural role, it is also a key player in cellular mechanotransduction 
processes and gene expression and epigenetic regulation. 
 Mutations in genes encoding for lamins are associated with a wide a range of diseases, named 
laminopathies. Among these, the most interesting one is Hutchison-Gilford Progeria Syndrome 
(HGPS), a rare fatal genetic disorder due to do a point mutation in LMNA. This mutation results in 
the production of a truncated version of lamina A, lacking 50 amino acids, known as Progerin. HGPS 
is mainly characterized by morphological changes in the nucleus and premature aging. HGPS patients 
indeed, from their first years of life, develop pathological conditions typical of the elderly such as 
cataracts, diabetes and osteoporosis while preserving the normal cognitive functions. These patients 
typically die from cardiovascular complications around 14 years of age, on average.  
Considering Hutchinson-Guilford Progeria Syndrome as an extreme example of what nuclear lamina 
aberration entails, during my PhD I investigated many aspects of nuclear lamina biology with 
particular regard to the impact of nuclear lamina structural perturbations on cell functions, 
mechanics, gene expression regulation and the interconnection existing between nuclear lamina 
integrity, ageing process and oxidative stress. 
Indeed, to gain a comprehensive picture of nuclear lamina biology in health and disease, it has been 
adopted interdisciplinary and integrative research strategies able to take into account structural, 
mechanical and molecular aspects. 
Bioinformatics study has been performed:  public available transcriptomic data of HGPS patients 
have been analysed with respect of those of healthy matched controls. This analysis allowed to 
delineate the typical global gene expression profile of HGPS patients and to identify all the 
deregulated pathways in the presence of the pathology. 
Moreover, impacts of lamina alterations on its physical and functional connections with extra-nuclear 
and nuclear elements have been studied in an inducible expression cellular model of the mutated form 
of Lamin A responsible for HGPS. This cellular model faithfully recapitulates the peculiar cellular 
phenotype of the HGPS patients resulting to be a valid alternative to primary cell lines deriving from 
the patients. 
Finally, the interdependence between oxidative stress, ageing and lamins has been investigated in a 
novel oxidative stress cellular model developed in our laboratory, that is also efficient in 
recapitulating typical ageing profile. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RIASSUNTO 
La lamina nucleare (NL) è un reticolo di proteine fibrillari che riveste la superficie interna della 
membrana nucleare. Essa è principalmente composta da filamenti intermedi di tipo V , chiamati 
lamìne, e proteine ausiliari ad esse associate (lamin-associated proteins, LAPs). Nei mammiferi le 
lamìne sono codificate da tre geni : LMNA, che codifica per la  lamìna  A e lamìna C (lamìne di tipo 
A), LMNB1 e LMNB2 che codificano rispettivamente per la lamìna B1 e B2 (lamìne di tipo B). 
Lamìne e LAPs si associano a formare una matrice tridimensionale densa e dinamica che stabilisce 
numerose interazioni, sia stabili che transitorie, con diverse classi di molecole biologiche: DNA, 
fattori di trascrizione, proteine strutturali. Tutte queste interazioni sono essenziali per fornire 
stabilità strutturale e preservare l’integrità nucleare, per collegare fisicamente e funzionalmente la 
lamina nucleare al citoscheletro e per organizzare la cromatina. In questo modo, oltre a svolgere un 
ruolo strutturale fondamentale, la lamina nucleare risulta ricoprire ruoli chiave anche nei processi di 
meccanotrasduzione del segnale e nella regolazione dell’espressione genica ed epigenetica. 
 Mutazioni a carico dei geni che codificano per le lamìne nucleari sono associate ad un'ampia ed 
etogenea classe di patologie note come laminopatie. Tra queste, una delle più controverse ed 
interessanti è la Hutchison-Gillford Progeria Syndrome (HGPS), una malattia genetica rara dovuta a 
una mutazione puntiforme nel gene LMNA. Tale mutazione risulta nella produzione di una versione 
tronca della lamìna A, mancante di 50 amminoacidi, conosciuta come Progerina. HGPS è 
principalmente caratterizzata da alterazioni morfologiche del nucleo e invecchiamento precoce. I 
soggetti affetti da Progeria, infatti, fin dai primi anni di vita sviluppano condizioni patologiche 
tipiche dell’età senile quali cataratta, diabete e l'osteoporosi pur preservando le normali funzioni 
congnitive. Questi pazienti muoiono tipicamente per complicanze cardiovascolari intorno ai 14 anni di 
età, in media. 
Considerando la sindrome di Hutchinson-Guilford come un esempio estremo di ciò che alterazioni 
della lamina nucleare comportano, durante il mio dottorato di ricerca ho investigato diversi aspetti 
riguardanti la biologia della lamina nucleare con particolare interesse all'impatto che perturbazioni 
strutturali della lamina nucleare possono avere sulle normali funzioni cellulari, la meccanica 
cellulare, la regolazione dell'espressione genica e l’ interconnessione esistente tra integrità della 
lamina nucleare, processo di invecchiamento e stress ossidativo. 
Per ottenere una visione d’insieme del contributo della lamina nucleare sia in condizioni fisiologiche 
che patologiche, sono state adottate strategie di ricerca basate su approcci interdisciplinari e 
integrativi in grado di tenere conto degli aspetti strutturali, meccanici e molecolari. 
Per fa questo, in prima instanza sono state effetuate delle analisi bionformatiche: tutti i dati di 
trascrittomica relativi a pazienti HGPS, presenti in database pubblici e in letteratura, sono stati 
raccolti e analizzati rispetto a dati equivalenti ottenuti da controlli sani. 
Tale analisi ha permesso di delineare profilo di espressione genica tipico di pazienti HGPS  e di 
individuare i pathways deregolati in presenza della patologia. 
È stato inoltre studiato l’impatto che alterazioni della lamina nucleare hanno sulle connessioni 
fisiche e funzionali che questa stabilisce sia con elementi  nucleari ed extra-nucleari, in un modello 
cellulare in cui è possibile indurre sperimentalmente, in modo controllato, l’espressione della forma 
mutata di Lamìn A responsabile dell’ HGPS. Tale modello cellulare ricapitola fedelmente il peculiare 
fenotipo cellulare dei pazienti risultando essere una valida alternativa all’utilizzo di  linee primarie 
derivanti dai pazienti. 
Infine, l'interdipendenza tra stress ossidativo, invecchiamento e lamìne nucleari è stata investigata in 
un nuovo modello cellulare di stress ossidativo sviluppato nel nostro laboratorio, efficiente nel 
ricapitolare il processo di invecchiamento, in vitro. 
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1 
Introduction
I. 1 Nuclear Lamina : an overview
The nuclear lamina (NL) is a well conserved cellular structure, present in all nucleated cells
of metazoa. NL is a thin, filamentous protein meshwork composed of nuclear lamins (Lamin
A, C and B) and lamin-associated proteins (LAPs), that line the inner surface of the nuclear
envelope (NE) forming a sort of 3D nuclear matrix which basically acts both as nuclear scaf-
fold, providing to the nucleus mechanical stability, and as a dynamic interface between the NE
and the residing DNA. Firstly characterized from the ultrastructural point of view in amphib-
ian oocytes [31], NL has been more recently also widely investigated in mammalian cells (all
reviewed in [20]). It is now well known that NL composition and architecture varies among
various organisms, from one tissue to another and during time (i.e. cell development and differ-
entiation). For example, while in amphibian oocytes NL is an ordered 10 nm filaments network
arranged in a regular woven meshwork pattern, in mammalian cells it has an irregular pattern
and resulted to be non-homogeneously distributed along nuclear inner surface but rather or-
ganised in alternate patches with high or low lamins concentration, with a thickness ranging
from 30 to 100 nm. NL is crucial for several structural and functional cellular processes: it
provides nuclear structural stability [88], it maintains nuclear shape and volume [56], preserves
intranuclear protein localization, organizes nuclear pore complexes (NPCs) [31] and, since it
serves as anchoring point for chromatin and transcription factors [21] at the nuclear periphery,
it actively participates in chromatin modelling and gene regulation [94]. Moreover, NL is also
involved in signal transduction between nucleus and cytoskeleton [44], cell cycle regulation [26],
cell development and differentiation, cell migration, and apoptosis[6]. The first notions of the
nuclear lamina functional and structural peculiarities derive from some studies in Xenopus lae-
vis oocytes and Drosophila melanogaster. In the early 90’s, it has been widely reported that NL
can bind chromatin. In particular, it has been observed that a fraction of chromatin appears
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to be in close proximity to the lamina during interphase [26] and that the binding of lamins
to decondensing chromosomes after mitosis is an initial critical step in nuclear reassembly in
both mammalian and Drosophila cell-free systems [65]. In addition, an intact lamina is re-
quired for DNA replication in nuclei formed from extracts of Xenopus laevis oocytes [15]. If
the Xenopus oocyte nuclear lamin protein is removed from the extracts, nuclei still form but
are unable to replicate DNA [15]. In addition, it has been isolated a Drosophila mutant which
is defective in producing wild type lamin Dmo showing impaired viability, fertility, and loco-
motion. Ultrastructural analysis of these mutants central nervous system revealed that lamin
Dm0 deficiency strongly affected structural integrity of the nuclear envelope and the proper in-
tegration of NPCs into the nuclear membrane [69]. Similar results have been obtained in Lmna
knockout mice where it has been observed that Lmna-/- slower growth after birth if compared
to the control group and mutant mice death by 5-6 weeks of age, with histologic evidence of
muscular dystrophy, cell nuclei aberrations and structurally weakened nuclear envelopes [88].
The functional importance of lamins is further supported by the finding that structural changes
in the lamina in human are among the most dramatic hallmarks of differentiation, cancer[6] and
aging.
I. 1.1 Architecture and structural role
Lamins are the main components of nuclear lamina. These are 60 to 80 kDa proteins
belonging to the superfamily of intermediate filament mainly consisting of a globular amino-
terminal domain (head) followed by a long α-helical rod domain and a carboxy-terminal domain
(tail) (Figure 1).
The central α-helical or rod domain represents approximately half of the lamin molecule
(about 350 residues) and comprises four α-helical segments (1A, 1B, 2A and 2B), each one
having a heptad-repeat periodicity and connected by short intervening subdomains (L1, L12
and L2). The C-terminal tail domain contains a nuclear localization signal (NLS) required for
the transport of lamins into the nucleus, an immunoglobulin-like structural motif (Ig-fold) and
a -CAAX box, fundamental for post-translational processing of lamins. Lamins are divided
into A-type and B-type lamins based on sequence homologies. Mammalian genome contains
three lamin genes: LMNA, LMNB1 and LMNB2. LMNA gene encode for Lamin A and for
Lamin C, an alternative splicing gene product (A-type lamins) while B-type lamins (Lamin B1
and Lamin B2) are respectively encoded by LMNB1 and LMNB2 genes. A-Type Lamins are
mainly expressed at later stages of development and in differentiated cells, B-types lamins are
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Figure 1: Domain organization of Nuclear Lamins in human and molecular 3D structure of alfa-
domain of Rod Domain and Ig Fold domain [22]
constitutively expressed. There are also three minor lamins isoforms : A∆10 [62], C2 (germ
line specific) and B3 [81]. Initially expressed as pre-lamins, nuclear lamins need a cascade series
of post-translational modification of their carboxy-terminal -CAAX motif to reach the mature
form. Lamins processing takes place in a highly regulated temporal sequence starting with
the farnesylation of the cysteine residue of the -CAAX box, followed by -AAX removal by an
endopeptidase, most likely Rce1 (Ras-converting enzyme 1) and/or Zmpste24 (Zinc metallopro-
tease related to Ste24p)/FACE1 [99] and a cysteine residue carboxymethylation catalyzed by the
enzyme isoprenylcysteine carboxyl methyltransferase (Icmt). While B-type lamins maturation
terms at this processing stage, resulting in their permanent farnesylation and carboxymethyla-
tion, Lamin A needs further processing steps. Indeed, to form mature Lamin A the removal of
additional 15 amino acids from its C-terminus, including the farnesylated/carboxymethylated
cysteine residue is required. Lamin A and lamin C are exactly identical for 566 amino acids but
lamin C lacks of 98 amino acids at the C-terminal domain respect to Lamin A. Thus, the main
difference between these two A-type lamins is that Lamin C has no -CAAX box at its C-term
domain.Once post-transcriptionally processed, lamins dimerize through their coiled-coil heptad
repeat pattern present in the rod domain forming the basic building blocks of higher-ordered
lamin assemblies. Then, lamins dimers associate one to another in a polar head-to-tail manner
obtaining lamins polymers that in turn, through anti-parallel association of two of these form
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lamin protofilaments. Finally, between three and four protofilaments associate laterally to form
an intermediate filament of about 10 nm in diameter ( Figure 2).
Figure 2: Schematic representation of model of lamin polymerization process [22]
The nuclear lamina assembly process has been widely studied. Some in vitro studies con-
ducted in bacteria expressing full-length and truncated lamin isoforms have revealed that both
the N- and C-terminal end domains are fundamental for the proper filament formation: N-
terminal head domain seems to promote lateral association of protofilaments and ultimately
10-nm filaments, while the C-terminal tail domain controls lateral assembly of protofilaments.
However in vivo significance is far from the light nowadays.
Interactions between A and B-type lamins are possible and necessary. As emerged from
in vitro binding assay, pre-Lamin A, Lamin A, Lamin B1 and lamin C can form homo- and
heterodimers when ectopically expressed in yeast [22]. Affinity chromatography with purified
lamins protein experiments also confirmed this result revealing that Lamin A and C could
directly interact with Lamin B in a heterotypic association occurring through a single binding
site, present at the N-term domain of Lamins A/C. Interestingly, some heterotypic lamins dimers
associations, such as B-A and B-C lamins, are stronger than heterotypic C-A, and homotypic
B-B and C-C. Some post-translational modification may strongly influence this strength of
interaction. For instance, phosphorylation of Lamin B causes a decrease in affinity for Lamin
A/C and, at the same time, an increased affinity for itself. This peculiar kind of lamins affinity
regulation by phosphorylation events has a strong impact on NL architecture and dynamics.
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Indeed, since phosphorylation events can manage and regulate the degree of heterotypic versus
homotypic association, they play a pivotal role in Nuclear Envelope break down process and
re-assembly that typically occurs during cell division.
I. 1.2 Functional roles
Nuclear Lamina and chromatin interaction
Tight apposition of a layer of condensed chromatin adjacent to the NL has been observed
with early electron microscopy [25]. Following, DNA fluorescence in situ hybridization (FISH)
revealed the presence of some genomic loci at the nuclear periphery, as also confirmed by DNA
adenine methyltransferase identification (DamID) experiments on several different cell types.
In particular, DamID technique gave as result a global chromatin association profiles of NL
components revealing that about 40% of the human genome is organized into about 1300 lamin-
associated domains (LADs), ranging from 10 kb to more than 10 Mb (Figure 3). Interestingly,
while some hundreds of genome regions change their association with NL in time (facultative
LADs) [61], most LADs are permanently associated with NL (“constitutive LADs”), in all the
analysed cell types [67].
Figure 3: Schematic representation of nuclear architecture and different levels of complexity of
NL-chromatin interactions [4]
In the light of these early experimental observations, LADs caught the researchers’ attention
for two main reasons. First, NL-LADs association may help in establish proper chromosome
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topology. Second, several different genes found in LADs show very low expression levels sug-
gesting LADs involvement in gene expression regulation, mainly gene repression. Indeed, it
has been widely reported that LADs exhibit several molecular feature typical of transcrip-
tionally inactive chromatin, such as histone modifications H3K9me2 and H3K9me3 typical of
heterochromatin [35], the facultative heterochromatin mark H3K27me3 and telomeric region
markers typical of the so-called pericentromeric heterochromatin. As expected, LAD are also
not enriched in DNA methylation [3]. Accordingly, it has also been referred that chromatin
detachment from the NL is frequently accompanied by gene activation while attachment to the
NL is frequently accompanied by gene inactivation [75]. Thus, NL proteins must be involved
in NL - LAD interactions and lamins are the more obvious candidates for this function. Some
ChIP studies have suggested that Lamin A/C have binding sites in inter-LAD regions [29, 61]
and some other experimental evidences show that B-type lamin depletion, in Drosophila, causes
chromatin detachment from the NL [85]. Nevertheless, although A- and B-type lamins differ in
their subcellular distribution, Lamin A and Lamin B1 DamID profiles are almost identical [47].
Accordingly, Lamin A knockdown leads to increased interaction of LADs with Lamin B [84].
Moreover, concerning lamins involvement in gene expression regulation, it has been recently
reported that the Polycomb group (PcG) proteins directly interact with Lamin A/C [64]. PcG
proteins are transcriptional repressors, present predominantly in the nucleus as multimeric pro-
tein complexes named Polycomb repressive complexes (PRCs) [82]. These complexes are able to
post-translationally modify histones and silence target genes acting as key epigenetic regulators
of the most important cellular processes. Notably, what it has been show is that Lamin A/C is
fundamental for correct PcG protein nuclear compartmentalization and functioning since Lamin
A depletion resulted in impaired PcG mediated transcriptional repression ( Figure 4) [13].
However, since deletion of all lamins in mouse embryonic stem cells has no evident effects on
DNA-NL association, this suggest that not only lamins mediate NL-LADs association but there
are also some other NL components involved. Among these, Nuclear Envelope Transmembrane
proteins (NETs) whose depletion or overexpression can alter chromosome localization [95] [60].
For instance, it has been discovered that Lamin B receptor (LBR), one of the most important
member of the NET proteins family, can directly bind to heterochromatin via its Tudor domain
and that Emerin, another member of the NET family, is required as cofactor in Lamin A/C-
DNA association to efficiently anchor chromatin to the NL [52] In particular, Emerin has been
reported to interact with LADs [48][35]tethering chromatin to the NL since it interacts with
NL proteins as well as chromatin components [2]. Interestingly, epidermal stem cells expose
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Figure 4: Schematic rapresentation of the molecular mechanism underlying PcG/Lamin A inter-
play [13].
to mechanical strain showed Emerin redistribution from the inner nuclear membrane to the
endoplasmic reticulum [76], followed by partial replacement of H3K9me2/3 by H3K27me3 his-
tone modification and changes in chromosome positioning inside the nucleus suggesting emerin
involvement in mechanosensory pathway signalling to heterochromatin [98]. Thus, several NL
proteins such as lamins, LBR, and emerin are components of a scaffold to which LADs are
anchored and that actively contribute to gene expression regulation [1].
Nuclear lamina role in cell mechanics
Cells are flexible building blocks of tissues that interact with each other in a dynamic
fashion and are continuously subjected to various kinds of mechanicals stress that mainly include
deformations by compression and stretching [44]. In the light of this, it appears clear that cells
must be able to face up to these various mechanical stimuli and adapt to them in order to
sustain their living functions.
Mechanotransduction is the process through which environmental mechanical stimuli gen-
erate cellular signalling events. The main mediator of this process is the cytoskeleton that,
because of its structural qualities, acts as a conductive-viscoelastic material transmitting force
and propagating stress within and between cells [46]. In this scenario, cell nucleus should not
be thought as an independent entity, rather it is closely linked to the cytoskeleton both me-
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chanically and functionally through NL and LINC complex (Linker of the Nucleoskeleton and
the Cytoskeleton)(Figure 5).
Figure 5: LINC complex representation [23]
Morphological changes to the nucleus in response to force were observed over 80-years
ago [36, 63]. It has been widely reported that external mechanical stimuli impact on nuclear
positioning [37], nuclear morphology [36, 70], and gene activity suggesting the presence of a
cell’s mechanotransduction pathways that orchestrate nuclear responses [33]. The LINC com-
plex links nucleoskeleton and cytoskeleton and it mainly consists of two major lamin-interacting
transmembrane proteins SUN1/SUN2 and Nesprin family proteins [16, 39]. Nesprins are high
molecular weight proteins associated with the nuclear membrane [103]. There are 4 different
nesprin proteins isoforms currently described: Nesprin-1 [101], Nesprin-2 [102, 54], Nesprin-
3 [97] and Nesprin-4. These associate with the inner or outer nuclear membrane depending
on their size. In particular, the larger isoforms, nesprin-1 and -2, associate with the outer
nuclear membrane exposing the N-term domain towards the cytoplasm and binds to microfil-
aments [16], and intermediate filaments [44]. In this way, they ensure nucleus-to-cytoskeleton
connection providing a strong anchorage of the nuclear membrane to the cytoskeleton that
is essential for migration and correct localization of the nucleus inside the cell. At the same
time, smaller Nesprin-1isoform is present at the inner nuclear membrane where directly binds
to Lamin A/C and emerin [43], a nuclear envelope transmembrane protein involved in NL-
chromatin interaction [53]. SUN-proteins associated with the inner nuclear membrane, with
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their carboxy-terminus in the perinuclear space, and their amino-terminus in the nuclear in-
terior [58] SUN proteins are necessary for the correct localization of nesprins to the nuclear
envelope, and can directly bind to lamins A/C [44]. Notably, The LINC complex has been
implicated in serving functions important for nuclear migration[27], positioning and morphol-
ogy. This evidence aligns with the current idea that lamina is essential for maintenance not
only of nuclear shape but also nuclear stiffness and structural integrity. NL and lamins play
also another crucial role in cell and tissue mechanics since cellular, and thus tissue stiffness
depends on A-type: B-type lamins stoichiometry [90] This can be derived from the fact that
different mutations in the genes for lamina proteins such as A- and B-type lamins, and emerin
are associated with a series of pathologies that are, among others, characterized by a reduced
resilience to mechanical stress[73]. Proteomic analysis revealed that Lamin A is 30 fold more
abundant in stiff tissue, such as cartilage, in comparison with soft tissue as brain or adipose
tissue where Lamin B is the dominant isoform [90, 89]. Consistently, micropipette aspiration
experiment performed on knocked down lamin-A human cells showed that knockdown nuclei
are softer [17]. Collagens in the extracellular matrix (ECM) are a key determinant of tissue
stiffness and scale with tissue stiffness whereas Lamin A levels respond to changes in tissue
elasticity [89]. Accordingly, when experimentally expose to mechanical stress stimuli on longer
time scales (hours-days), the nucleus can alter its stiffness to reflect the stiffness of the cellular
microenvironment [89]. This stiffness regulation seems to be mainly due to Lamin A solubil-
isation which is mediated by stress-dependent phosphorylation events: low mechanical stress
favours Lamin A phosphorylation and possibly Lamin A solubilisation.
I. 2 Laminopathies
Nuclear lamina is an essential component of metazoan cells since it is involved in most nuclear
activities including DNA replication, RNA transcription, nuclear and chromatin organization,
cell cycle regulation, cell development and differentiation, nuclear migration and mechanotrans-
duction, as previously reported. In the last three decades, the interest for NL and its compo-
nents has exponentially grown because of the discovery of several mutations in genes encoding
for lamins which are responsible for the onset of the so called laminopathies [5, 83, 8, 68].
Laminopathies are 17 genetic disorders with a broad clinical spectrum, all caused by mutations
in lamins or in lamins functional-related genes. Laminopathies can be classified depending on
the affected tissue and depending on the gene in which the causative mutation occurs. Indeed,
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laminopathies can be tissue-specific, if the mutation affects somatic cells belonging to a certain
tissue, or systemic, if mutation affects all or almost all cell types [100]. Moreover, they can
be classified as primary laminopathies, referred to those caused by mutations on Lamin A or
secondary laminopathies, those due to mutations in B-type lamins genes, prelamin processing
proteins (such as Zmpste24) or lamin binding proteins (i.e. emerin). Notably, about 90% of the
mutations causing laminopathies occurs in LMNA gene and more than 400 mutations in the
Lamin A gene have been identified from patients [93]. Each mutation has a very wide range
of phenotypes, and the genetic features vary such that in some cases function is gained, while
in others function is lost. However, what is common among all these pathologies is that the
cell nuclei of affected people have abnormally shaped nuclear envelopes showing herniations or
honeycomb structures of the lamina and the lamin-associated proteins [11], resulting in me-
chanically weakened nuclei that rupture more easily under mechanical loading [80] [50]. These
effects on the nuclei however, are not sufficient to completely explain the general cell functions
impairment observed in affected tissues. Three models have been proposed to explain the link
between the mutation of the LMNA gene and the observed pathologies:
• The ‘gene regulation’ hypothesis according to which, in particular A-type lamins play a
regulatory role in specific DNA-transcription by activating mechanosensitive genes [91].
• The ‘structural’ hypothesis which states that lamins play an essential role in the struc-
tural integrity of the nucleus and thus in the structural integrity of the whole cell, via
connections between nuclear lamina, cytoskeleton and extracellular matrix [80, 50] taking
in account that nuclear lamina aberration not only influence cell mechanics but can also
result in disturbed signaling cascades.
• The “DNA-damage hypotesis” according to which lamina alterations cause DNA repair
mechanism impairment, leading to premature aging of cells and tissues [32, 87]. Presum-
ably, given the relevance of NL both in structural and in functional cellular aspects, these
three hypotheses do not exclude each other.
Although mutations on Lamin A induce various types of diseases, the most interesting
feature is their promotion of premature aging. Since the aging process is believed to be the
result of a series of complex overlapping physiological mechanisms, it is astonishing that a single
mutation on Lamin A is able to promotes the aging process [100]. Firstly described in 1886
by Jonathan Hutchinson that reported some clinical informations about “ a 31 years-old boy
with congenital absence of hair and mammary glands with atrophic condition of the skin and
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its appendages” [45], Hutchinson-Gilford Progeria Syndrome (HGPS) was better described by
Hastings Gilford in 1897. He decided to name this syndrome “Progeria” from the greek words
“pro”, meaning “premature”, and “ge`ras”, meaning “old age” [30], because all the affected
patients displayed, since childhood, all the peculiar features typical of the elderly (Figure6)
such as sarcopenia, osteoporosis, diabetes, cataracts, and atherosclerosis except cancer and
neuro-degenerative diseases [30, 19], however preserving cognitive functions [71, 14].
Figure 6: Dutch HGPS patient in its growth and arising of typical phenotype ( figure from [41])
HGPS patients usually die from cardiovascular complications at around 14 years of age [14].
HGPS is a very rare (1: 20,000,000)[14], fatal genetic disorder due to a base pair substitution
at exon 11 of the Lamin A gene (c.1824C>T, p.G608G), at least in 90% of all HGPS cases [79].
Mutation is spontaneous and typically occurs, de novo, during gametogenesis or in fertilization
period. Nowadays, there are 154 HGPS affected patients all around the word [source:Progeria
Research Foundation], with a similar sex ratio between two genders. Interestingly, even though
this de novo heterozygous silent mutation does not change the aminoacidic sequence of the wild
type Lamin A protein, it generates a donor cryptic splicing-sites that causes the production of
a mutated form of Lamin A lacking of 50 amino acids, known as Progerin [18]. Since this 50
amino acid deletion results in Zmpste24-cleavage sites loosening, ∆50Lamin A cannot undergo
the physiological post-translational processing thus remaining permanently farnesylated. This
property tethers Progerin to cell’s inner nuclear membrane, likely permanently thus preventing
its proteasome-mediated elimination (Figure 7). As a consequence, Progerin accumulates into
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the nucleus leading to nuclear morphologic alterations, shortened telomere length, increased
DNA damage foci, a decrease of heterochromatin levels [7] and general impairment of all the
processes in which NL is actively involved [9] [57] [72].
Figure 7: On the left, Lamin A physiological processing and insertion in nuclear lamina. On the
right, what happens in presence of mutated Lamin A. [49]
Notably, also normal aged cells show Lamin A aberrant localization, low levels of heterochro-
matin, nuclear blebbing and increased levels of Progerin [78] which it has been reported to be
sufficient itself to induce all the nuclear abnormalities characteristic of HGPS. These support
the raising belief according through which the accelerate aging displayed in HGPS is a phe-
nocopy of the physiological aging process [59]. Despite strenuous efforts have been made to
understand molecular mechanisms underlying the onset of the pathology, progeria is still an in-
curable disease.Basically, all the therapeutic strategies target post-translational modifications of
Progerin. Initial preclinical studies identified farnesyltransferase inhibitors (FTIs) [92, 12] and
prenylation inhibitors (statins and aminobisphosphonates) as potential beneficial treatments
for HGPS. Unfortunately, the first clinical trials for children with progeria utilizing the FTI
lonafarnib lone and lonafarnib, pravastatin and bisphosphonates in combination reported no
significant improvements in patients quality of life and lifespan. More recently, additional ther-
apeutic strategy are emerging consistently with the notion that reduced expression of ICMT, the
enzyme responsible for carboxymethylation of the farnesylcysteine of Lamin A/Progerin, has a
dramatic effect ameliorating the phenotype of progeria mice, significantly increasing lifespan. In
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addition, other reports have shown a beneficial effect of rapamycin [34, 10] and sulphorafane [28],
a chemotherapeutic and a natural antioxidant respectively, on the phenotype of HGPS patient
cells by increasing Progerin clearance by autophagy. Moreover, resveratrol, an enhancer of
SIRT1 deacetylase activity, alleviates progeroid features and extends lifespan in progeria mice
model, although the effect on survival is relatively modest [55, 23].
I. 3 Nuclear Lamina, Oxidative Stress and Ageing
Oxidative stress refers to a cell state during which there is an unbalance between the produc-
tion of reactive oxygen species (ROS), physiological by-products of mitochondria metabolism,
and ROS elimination. Living cells have developed several defence mechanisms, both enzymatic
and non-enzymatic, through which ROS amount is kept at tolerable levels. However, there are
some cases in which the balance between ROS production and elimination is shifted so much
in favour of ROS production, that these defence systems fail to counterbalance the adverse ef-
fects of ROS on cellular macromolecules. Indeed, while moderate physiological increase in ROS
levels results in cell proliferation and differentiation promotion [77], ROS overload causes DNA,
proteins, and lipids damages leading to cell proliferation and longevity impairment [86].In the
last 60 years, ROS have been one of the most addressed topics in biomedical research mainly
because of the widely reported relation existing between oxidative stress and aging. While in
the common vision aging is just the natural process of becoming older, in the biomedical re-
search field aging is defined as a complex, continuous and irreversible process that affects all
cell type and organs, during which most of the crucial physiological functions are impaired and
lost. Firstly proposed by Denham Harman, “the free radical theory of ageing” [40] claims that
ageing is the cumulative result of oxidative damage. Since this theory came out in ‘50s, several
thousand of studies reported that ROS levels and oxidative damage increase with increasing
age [66, 38] and that reducing oxidative damage extends the lifespan of various animal models
(i.e. : yeast, fruit flies, mice, etc.) [42]. Exogenous Hydrogen peroxide (H2O2) exposure, is
sufficient to induce premature cellular senescence in wild type fibroblasts recapitulating aging
process profile [24]. More recently, several studies also referred the presence of a strong inter-
dependence between oxidative stress and lamins. More specifically, it has been observed that
lamins depletion and lamins genes mutation negatively impact on oxidative stress response and
adaptation mechanism which in turn are tightly coupled to cell proliferation, longevity, cellular
senescence, apoptosis and autophagy. Conversely, oxidative stress influences lamins expression
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and stability by interfering in physiological lamins post-translational modification processing.
For instance, increased ROS lead to the oxidation of cysteine residues in the Lamin A tail do-
main which promotes the formation of Lamin A inter- and intramolecular disulphide bonds [74].
Interestingly, high levels of ROS, such as superoxide radical (O2 -), hydrogen peroxide (H2O2 ),
singlet oxygen, and hydroxyl radical (OH) have been detected in HGPS fibroblasts, as well as
in normally aged fibroblasts, contributing to increase levels of DNA damage and nuclear shape
alterations ( Figure 8) [51, 96].
Figure 8: Shape similarity between aged healthy fibroblasts of 96y patients (B) and HPGS fibrob-
lasts (C), young healthy fibroblast ( A ) as control. Lamin A/C in red. [78]
This, seems to be due to the Progerin capability to sequester NRF2, a transcription factor
that regulates genes harbouring antioxidant response elements (ARE) and that activate an-
tioxidant response signalling pathway. The sequestration of NRF2 by Progerin prevents NFR2
transcriptional activity resulting in increased chronic oxidative stress ( Figure 9). In addition,
Progerin was also found to be expressed in old wild type fibroblasts, that exhibit an altered
dimorphic nuclear profile as in progeria patient-derived fibroblasts [78].
Since physiologic ageing process and HGPS share some clinical features ( Figure 9), it would
be of great relevance better understand and characterize the molecular mechanism underling
Progeria onset in order to shade light on normal aging and viceversa.
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Figure 9: Schematic representation of a wild type cell nucleus and HGPS one, showing Progerin
capability to sequester NFR2 thus ROS accumulation [78].
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Outline
During my PhD I investigated many aspects of nuclear lamina biology with particular regard
to the impact of nuclear lamina structural perturbations on cell functions, mechanics and gene
expression regulation. Moreover, I also investigated the effect of “chemical environmental” on
nuclear lamina structure and functions in a cellular model that faithfully recapitulates, in vitro,
aging process.
The present thesis is divided into three chapters whose contents result into three scientific
publications:
• Chapter 1: Since nuclear lamina interacts with DNA and it has been reported to be
actively involved in gene expression regulation we evaluated the effect Progerin on global
gene expression regulation. To do this, our group performed a bioinformatics study in
which all public available transcriptomic data of HGPS patients have been analysed with
respect of those of healthy matched controls. As result we obtained a list of the most
deregulated genes and we identified the pathways deregulated in presence of the pathology,
to which these genes belong.
Title : “Pathway deregulation analysis in Hutchinson-Gilford Progeria Syndrome.”
Authors : Francesc Font-Clos, Maria Chiara Lionetti, Stefano Zapperi and Caterina
A.M.La Porta.
Journal : Scientic Reports, under revision.
• Chapter 2: Herein, I report the results obtained while studying the impacts of nuclear
lamina alterations on nuclear plasticity and nucleus interaction to cytoskeleton, in an in-
ducible cellular model of mutated Lamin A.
Title : “Effects of Progerin on nuclear cell plasticity”
Authors : Maria Chiara Lionetti, Federico Mutti, Maria Rita Fumagalli, Francesc Font-
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Clos,Giulio Costantini Stefano Zapperi and Caterina A.M.La Porta.
in preparation
• Chapter 3: In this last chapter, I report the results obtained studying the interdepen-
dence between ROS, ageing and lamins in a novel oxidative stress cellular model developed
in our laboratory. In particular, I studied the impact of “chemical” environment on nu-
clear lamina structure and related functions, and the possible reversibility of the oxidative
stress effects by anti-oxidant supplementation.
Title : “Sulforaphane can not protect the cells to a repeated, short and sublethal treatment
with hydrogen peroxide”
Authors : Maria Chiara Lionetti, Federico Mutti, Erica Soldati, Maria Rita Fumagalli,
Graziano Colombo, Emanuela Astori, Aldo Milzani, Isabella Dalle Donne, Emilio Ciusani,
Giulio Costantini, Caterina A. M. La Porta,
Journal : Journal of Nutrition Biochemistry, under revision
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Abstract
Hutchinson-Gilford progeria syndrome (HGPS) is an autosomal dominant aging disease involving
lamin A, a protein that plays a crucial role in the nuclear scaffold. The cause of the disease is still
unknown although it was recently proposed that it could involve an impairment of mesenchymal
lineage differentiation. We have tackled this problem by performing a pathway deregulation anal-
ysis of HGPS transcriptomes with the aim of identifying a characteristic gene expression signature
that might shed light on the most important features of the disease and suggest possible prog-
nostic/therapeutic targets. Our findings highlight two new and interesting aspects: first we found
that the most deregulated pathway in HGPS subjects is the epithelial-mesenchymal transition
(EMT), suggesting that this pathway should be targeted by therapeutic intervention or used for
prognosis. The second interesting possible target emerging from our analysis is PTX and CCL2
which play a critical role during inflammation and therefore could be involved in many of the
clinical consequences of this complex disease.
Introduction
Hutchinson-Gilford progeria syndrome (HGPS) is an autosomal dominant, rare, fatal pe-
diatric segmental premature aging disease [1] belonging to a family of genetic diseases called
laminopathies [2]. The diagnosis is based on common clinical features and detection of heterozy-
gous lamin A (LMNA) pathogenic variants either within exon 11 (classical) or at the intronic
border of exon 11 (atypical). LMNA is the only gene in which pathogenic variants are known to
cause HGPS. The lamin proteins are the principal components of the nuclear lamina, a complex
molecular interface located between the inner membrane of the nuclear envelope and chromatin [3].
In HGPS, a mutation produces a shortened abnormal protein, called progerin, with a 50 aminoacid
deletion near its C-terminal end. This deletion does not affect the ability of progerin to localize
into the nucleus or to form a complex with the normal Lamin A protein, but the sites for the
proteolytic cleavage of the terminal 18 amino acids and the farnesyl side group of prelamin A
∗Caterina A. M. La Porta
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along with the phosphorylation site involved in the dissociation and re-association of the nuclear
membrane at each cell division are removed in progerin [4, 5].
HGPS patients show characteristic craniofacial features and cardiovascular disease that con-
stitute the major cause of morbidity and mortality. The disease progression displays many of
the symptoms of normal aging, such as progressive atherosclerosis, while other symptoms such as
neural degeneration, diabetes, malignancies and cataracts are absent. Samples from biopsy and
autopsy are limited due to the rarity of the disease and therefore most information comes from
studies on patient-derived skin fibroblasts, wild type and mutant lamin A overexpression in estab-
lished cell lines [2, 3]. The clinical strategy up to now is based on the use of farnesyltransferase
inhibitors and anti aging treatment with rapamycin and resveratrol [6]. The cause of the disease
is still unclear and many hypothesis are under investigation: progerin-mediated stem cell pool
exhaustion [7], mesenchymal lineage differentiation defects [8], a diminished DNA-damage repair
response [9] and nuclear fragility in mechanically stressed cells such as cardiomyocytes [10].
In this paper, we approach this problem using pathway deregulation analysis of progeria tran-
scriptomes to identify a characteristic gene expression signature associated with progeria that sheds
light on the most important features of the disease with the ultimate goal of identifying interesting
key targets.
Results
Transcriptomic signature of HGPS
We collect from the existing literature a set of six experiments reporting transcriptomic data
from HGPS patients, matched with healthy controls. The latter are human dermal fibroblasts
obtained from healthy subjects. We could not find enough data from parents of HGPS patients.
Altogether the data contain 34 HGPS samples and 38 healthy controls. In dealing with samples
coming from different experiments, we are faced with the thorny issue of batch effects. It is
not possible to naively merge all the data sets into a unique pool, since each experiment has its
characteristic features that must be removed in order to uncover the biological signal. We have
successfully addressed this problem in the context of obesity by using the method of singular value
decomposition. We apply the same strategy here (see the Methods section) and find a set of 62
differentially expressed genes (FDR 10−4) when comparing HGPS and healthy subjects.
Figure 1 reports the 62 genes and displays the fold change in the expression level and a measure
of statistical significance (the p-value according to the Kolmogorov-Smirnov test) for each batch
separately.
The 62 genes can be subdivided into two groups: the group of down-regulated genes (col-
ored in blue in Figure 1) and the group of up-regulated genes (colored in red in Figure 1). The
down-regulated genes group includes genes involved in microtubule dynamics (STMN2), genes
involved in vascular remodeling (CTHRC1, S1PR1, MMP3, HAS2, MXRA5), in Wnt-pathway
(SFRP1), in protein folding (CLEC2B) and erytrocytes (EPB41L3). On the other hand, among
the up-regulated genes we find genes involved in neuronal excitability (SCN3A),in cardiac conduc-
tion (KCNE-4), in the migration and differentiation of muscle cells (ITGA7, MYOCD, MEOX2,
ANKRD1, PPP1R14A), in inflammation (PTX3, CCL2) and finally a gene involved in the con-
nectivity of neurons (PCDH10). The overall picture reveals an impairment of specific functions
related to endothelial and muscle cells as well as a general state of inflammation that could help
explain the most important symptoms displayed by HGPS subjects such as atheroscelrosis and
cardiovascular disease. On the other hand, it is possible to point out a general preservation of the
brain functions.
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Pathway deregulation in HGPS with respect to healthy subjects
We use Pathway Deregulation Scores (PDS) to estimate the overall deregulation of each path-
way in each sample (for the computational details, see Methods). Figure 2a shows boxplots of
HGPS samples (colored from red, strong deregulation, to pale blue, no deregulation) and of con-
trol samples (thinner, colored in gray). It is apparent that a number of pathways are appreciably
deregulated. We assess the statistical significance of these clear differences by means of fold-change
of median group values, comparing HGPS to control samples, and sort the pathways accordingly.
Pathways marked with gray circles have FDR < 10−3. Remarkably, the pathway with highest
deregulation is the epithelial mesenchymal transition (EMT) pathway. KRAS signaling is also
significantly deregulated as well as TNFα signaling, both possibly related to EMT and inflamma-
tion processes. Impairment of coagulation is also among the significantly deregulated pathways
and is involved in many biological processes including inflammation. Figure 2b shows an example
of the PDS projection for the EMT pathway: the segregation of HGPS samples with respect to
healthy ones is clear. The data is further projected onto its first 3 principal components to allow
for visualization. The axis display the proportion of explained variance. Figure 2c gives an overall
view of pathway deregulation in HGPS transcriptomes by displaying a heatmap of PDS values.
Role of farnesyltransferase inhibitors
We have checked if the observed deregulation depends on the effect of treatment with farne-
syltransferase inhibitors (FTI). One of the batches studied (E-MEXP-2597, see Datasets section)
contains 10 samples treated with FTI. When we remove those samples from the analysis we find
an HGPS signature that is very similar the original one (it is composed of 56 genes, 54 of which
are part of the original signature). Furthermore, the ranking of the pathways obtained without
the samples treated with FTI is again very similar and the top five pathways (including EMT and
KRAS) are the same. Hence, we conclude that the pathway deregulation we observe is not an
effect of the treatment with FTI but is associated with HGPS.
Experiments
We experimentally validate the deregulation of the EMT pathway assessing the level of expres-
sion of some known markers of mesenchymal state such as β-catenin and vimentin by immunoflu-
orescence. We use fibroblasts derived from one HGPS subject and from his/her healthy parents.
As shown in Figure 3, both β-catenin and vimentin mesenchymal markers are mainly expressed in
the healthy father with respect to HGPS. In fact, β-catenin is mainly expressed in the cytoplasm
and at the edge of the plasma membrane while in the healthy father it is expressed in the nucleus,
where this factor translocates when active. Accordingly, vimentin is down regulated in the HGPS
subject.
Interaction between lamins and HGPS signature
We perform a centrality analysis of the interaction network between lamins and the HGPS
signature, see Methods for details on how the network was constructed. Figure 4a shows the
interaction network, with seed nodes colored in pale green (LMNA), dark green (LMNB1) or
red(HGPS); and the rest of nodes colored in gray and positioned according to which clusters of
seed nodes they connect to.
Figure 4b is a coarse-grained representation of the same network: nodes represent clusters in
panel a, and connections are aggregated so that the width of the arrows is proportional to the
number of directed connections between two clusters. The panel shows a characteristic group of
central nodes that facilitates the cross-talk between lamins and HGPS-related genes. To further
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asses the centrality of such nodes, we compute 4 well-know centrality measures (see methods for
details).
Figure 4c displays a heatmap of centrality values, with nodes ranked according to their average
ranked centrality. This ranked list should highlight the nodes that are more central in the interac-
tion between lamin related genes and our HGPS signature. The most central nodes according to
this analysis include factors involved in the control of the cell cycle such as CCND1, CDK1, Cyclin
A and YAP, factors which play an important role in kinetochore such as AURKB, SPC25, NDC80,
MAD2L2, transcription factors such as NFkB, E2F, SOX9,CREB that control many functions
from the proliferation to differentiation and development, factors involved in controlling apoptosis
such as BIRC5, AkT, ERK1/2, chemokines or such as CCL2, IER3 and factors regulating the
extracellular matrix MMP3, HAS2. Therefore, this kind of analysis allow to highlight the most
important functions impaired in HGPS subjects that are involved in their severe phenotype.
Discussion
HGPS is a rare disease that is at present impossible to cure. The most common form of HGPS
is caused by a de novo heterozygous point mutation in the human lamin A gene. Progeria is
usually diagnosed in the first year or two of life and is characterized by a rapid progression of
aging phenotypes. In spite of a severe atherosclerosis, cardiac or cerebrovascular disease, these
subjects show a normal motor and mental development. The analysis of data contains 34 HGPS
samples and 38 healthy controls by the aim of pathway deregulation score shows a clear impairment
of EMT in progeria subjects, the latter being in agreement with the hypothesis of an exhaustion
of stem cells in these patients [7] or mesenchymal lineage differentiation defects [8]. Accordingly,
the level of expression of typical mesenchymal markers such as vimentin and β-catenin nuclear
localization confirms the loss of a mesenchymal phenotype in HGPS fibroblast cells in comparison
to healthy subjects. Interestingly, HGPS patients show the decrease of a set of genes involved
in critical cell functions related to microtubule dynamics, vascular remodeling, stem-related genes
(Wnt-pathway) and protein folding.
This kind of analysis can not help in understanding the cause of the disease but is useful to
highlight important hubs hit by the disease and maybe identify possible new interesting marker.
In this case, EMT seems to play a critical role in the disease and therefore every treatment
that could improve vascular remodeling may provide a good strategy to improve the functions of
HGPS subjects. Another interesting aspect come out form our findings: we have seen a general
improvement of neurotransmission and connectivity between neurons, explaining the intact brain
function of HGPS subjects and the absence of neurodegenerative disease. On the pother hand,
inflammation is another important aspect of this disease that lead to a severe phenotype. PTX3
and CCL2 appear to be interesting targets triggering inflammation. PTX in fact is considered
an essential fluid-phase pattern recognition molecule of the innate immune system that acts as
a functional ancestor of antibodies which plays a critical role in tissue repair [11] and CCL2 is
involved in the recruitment of mococytes during infection and inflammation [12]. Muscle cells are
also target linked to the severe phenotype of HGPS subjects and interesting target involved both
in the migration and differentiation are also highlighted by our data.
The overall picture reveals an impairment of specific functions related to endothelial and muscle
cells as well as a general state of inflammation that could help explain the most important symp-
toms displayed by HGPS subjects such as atheroscelrosis and cardiovascular disease. In contrast,
brain functions appears to be preserved.
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Methods
Human Fibroblasts culture growth conditions
Human fibroblasts from HGPS patient (HGSDNF167) and the relatives of this patient (
HGFDNF168 and HGMDF090, father and mother, respectively) are obtained from the Progeria
Foundation Cell and Tissue Bank. The HGPS patient was a male of 8 years old with the classical
mutation (heterozygous LMNA Exon 11 c1824 C>T (p.Gly608Gly). The cells were maintained
according to the protocol reported by The Progeria Foundation: 15% FBS, DMEM with 1% an-
tibiotics and 1% L-glutamine. The cells were detached by trypsin EDTA 25% and are maintained
in culture for no more than five passages.
Immunofluorescence
Subconfluent cells grown on glass coverslips are fixed with 3.7% parafolmaldeide in PBS for
10min, permealized with 0.5% Triton X-100 in PBS for 5min at room temperature and incu-
bated with 10% goat serum in PBS for 1hr. The cells are stained with anti-β-catenin (anti-
ActiveβCatenin, Millipore, 05-665, 1:50) or anti-vimentin (sc-53464, Santa Cruz 1:50) overnight at
4 ◦C. Thus, after a brief washing with PBS, the cells are incubated with the secondary antibody
(anti rabbit or anti-mouse Alexa488 1:250) for 1 h. The cytoskeleton is stained with Falloidin
(Acti-stain 555 Fluorescent Phalloidin, Cytoskeleton Inc, 100 nM) at room temperature for 45
min. The nuclei are counterstained with DAPI and the slides mounted with Pro-long anti fade
reagent (Life technologies). The images are acquired with a Leika TCS NT confocal microscope.
Transcriptomic data pre-processing
We apply the following pre-processing steps to all transcriptomic data: 1) Probes containing
missing values are excluded from the analysis. 2) Probes are mapped to Entrez ID labels if they are
available in the associated platform. Otherwise the David portal is used to convert the available
labels to Entrez ID labels. 3) Values corresponding to raw expression counts or gene expression
intensity are log2 transformed (if necessary). 4) Probes mapping to the same Entrez ID label are
averaged out. 5) Probes that cannot be mapped to a unique Entrez ID label are excluded from
the analysis, as well as those that cannot be mapped to any Entrez ID label at all. 6) We apply a
simple normalization in linear space, imposing that the mean of expression of each gene is constant
among samples.
Batch effects removal
We use the SVDmerge algorithm to remove batch effects. The details of the algorithm are
explained in [13]. In short, SVDmerge uses singular value decomposition to identify which “eigen-
genes” or directions in gene-expression space correspond mostly to the phenotype of interest
and which can rather be associated to batch effects. In addition, by ranking the eigengenes via
Kolmogorov-Smirnov tests, the algorithm can selectively filter out eigengenes associated to batch
effects, minimizing the total distortion of the original data.
Calculation of Pathway Deregulation Scores
We compute Pathway Deregulation Scores (PDS) as explained in [13] for the set of 50 hallmark
gene sets or pathways from the MSigDB [14]. For each pathway and each sample, PDS gives a
unique value that can be associated to the overall deregulation. Taking together the PDS values of
HGPS and control samples, we can confidently establish if a pathway is consistently deregulated in
HGPS: it is expected that, under strong deregulation patterns, samples of the same group cluster
together in terms of PDS values.
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Construction of HGPS-lamins interaction network
LMNA and LMNB related datasets have been composed from genes found in the immediate
neighborhood of the laminin genes in functional (STRING [15], IPA [16]) and gene co-expression
(Genevestigator [17]) networks as well as proximal to LMNA and LMNB genes in their gene loci.
The lists are shown in Tables 2,3 and 4. To investigate interactions between the LMN- associated
genes and the genes from the defined progeria signature we have reconstructed functional net-
works from the combined gene sets using IPA. The Core analysis using the IPAs knowledge base
gene/protein connectivity data for human and rodents was performed and the most densely inter-
connected and top-ranked seed networks were selected. The seed networks of directly connected
gene-nodes were allowed to automatically expand up to maximal size of 70 nodes by addition of
top-ranked connecting functions from the IPA knowledge base. This procedure would increase a
continuity of networking within the uploaded gene set.
Centrality measures
Centrality measures are a very important set of algorithms in network science. They are used
to asses the “importance” or “centrality” of nodes in a network according to different criteria. The
choice of the criterion and hence of the most convenient algorithm is a delicate issue in general,
and certainly has no unique answer in many cases. A common strategy is then to compute several
centrality measures and look for nodes consistently identified as central by most algorithms. We
compute Katz centrality [18], eigenvector centrality [19], betwenness centrality [20] and PageRank
centrality [21]. We use the implementation of graph-tool [22], an efficient network-analysis python
package. The mathematical definition of the four measures and details about the implementation
can be accessed at ref.[23].
Data
A total of six transcriptomic datasets are gathered from the available literature. Here we briefly
describe them, giving references to the associated original publications and accession codes from
either GEO or ArrayExpress. (E-MEXP-2597): Dermal fibroblasts from five subjects with HGPS
aged 1 to 4 and five age-matched dermal fibroblast control cell lines, see [24] for details. Two
samples per subject are used, totaling 20 samples. (E-MEXP-3097): Primary skin fibroblasts from
an autosomal recessive HGPS family, see [25] for details. Three affected homozygous samples
and three healthy control samples were included in our reanalysis. Three samples from healthy
heterozygote carriers were discarded. (GSE3860): Dermal fibroblasts from three HGPS cell strains
and three age-matched control cell strains, see [26] for details. Three biological replicates per
subject were included in the analysis. (GSE28863): Dermal fibroblast from two HGPS cell lines
and three normal cell lines, see [27] for details. Two biological replicates per subject. Due to
unmatching labels between [27] and GSE28863 it is not possible to determine if there is any
family relationships between HGPS and control subjects. (GSE41751): Primary fibroblast cell
lines from one HGPS subject, its father (normal phenotype), and one age-matched control, (two
biological replicates per subject totaling 6 samples, see [28] for details). (GSE69391): A total of
12 samples obtained from primary dermal fibroblast cell lines from HGPS subjects and control
dermal fibroblast cell lines.
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Figures
a)
b)
Figure 1: A transcriptomic signature of progeria. Overview of the 62 genes in the progeria signature among
each of the 6 original datasets. (a) Fold-change values with red (blue) shades indicating over-expression (under-
expression) in progeria with respect to healthy samples. Values between −0.5 and 0.5 are shown in gray. (b) P-values
in a Kolmogorov-Smirnov test comparing progeria and healthy samples (FDR adjustment with Benjamini-Yekutieli
method). Darker shades of green correspond to smaller p-values. Values corresponding to FDR > 0.05 are shown
in gray.
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Pathway Deregulation Scores
We compute PDS for all 50 pathways in 
the hallmark gene sets collection of 
the MSigDB (Broad Institute). 
Boxplots of PDS distribution in progeria 
samples. Color indicates median PDS: 
Boxplot of PDS distribution in healthy 
samples. Mean PDS is set to zero. 
Pathways selected with Gene Set Over-
representation Analysis (FDR<0.1) 
Pathways with FDR<0.001 in a KS test 
between healthy and progeria samples. 
The gray intensity indicates the FDR-
corrected p-value: Raw data 
Projected data 
Principal curve
Control samples 
HGPS samples
Epithelial mesenchymal 
transition (EMT)
c)
b)a)
Low
High
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S
Figure 2: Pathway Deregulation Scores (PDS). We compute PDS for the 50 “hallmark gene sets” from
MSigDB. (a): Boxplots showing the distribution of PDS values for each pathway, both for healthy samples (gray,
thin boxplots) and for progeria samples (colored,thick boxplots; coloring corresponds to median of progeria samples).
Pathways are sorted by their median PDS among progeria samples. The median of healthy samples is set to zero.
The gray circles placed at the right border of the boxplots indicate a FDR-corrected p-value below 10−3, in a
Kolmogorov-Smirnov test comparing progeria and healthy PDS values. Darker shades indicate smaller, more
significant p-values. Black stars mark those pathways where the progeria signature genes are significantly over-
represented (hypergeometric model, FDR-adjustment Benjamini-Yekutieli method, FDR > 10−1). (b): Projection
(black small circles) of the original transcriptomic data (colored circles) onto its principal curve (black line). The
data is further projected onto its three first principal components for visualization purposes only. The panel shows
that progeria and healthy samples cluster separately, indicating a strong deregulation of the “Epithelial mesenchymal
transition” pathway. (c): Full PDS matrix. Pathways are place in columns and numbered H1-H50 as in panel (a).
Samples are placed in rows and are sorted by their PDS value in the H1 pathway.
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Figure 3: Mesenchymal markers in an HGPS patient with respect to his parent. Human fibroblasts
from HGPS patient (HGSDNF167) and his father (HGFDNF168) are obtained from the Progeria Foundation Cell
and Tissue Bank. Subconfluent cells grown on glass coverslips are fixed with 3.7% parafolmaldeide, permealized
with 0.5% Triton X-100 and incubated with 10% goat serum in PBS for 1hr. The cells are stained with (panel a)
anti-β-catenin (anti-ActiveβCatenin, Millipore, 05-665, 1:50) or (panel b) anti-vimentin (sc-53464, Santa Cruz 1:50)
overnight at 4◦C. Thus, the cells are incubated with the secondary antibody (anti rabbit or anti-mouse Alexa488
1:250) for 1 h. The cytoskeleton is stained with Falloidin (Acti-stain 555 Fluorescent Phalloidin, Cytoskeleton Inc,
100 nM) at room temperature for 45 min. The nuclei are counterstained with DAPI and the slides mounted with
Pro-long anti fade reagent (Life technologies). The images are acquired with a Leika TCS NT confocal microscope.
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Figure 4: Interaction network between lamins and HGPS signature. (a): Interaction network with seed
nodes colored and the rest of nodes in gray. Nodes are positioned according to which seed-nodes clusters they
connect to. (b): Same, with clusters displayed as nodes (size proportional to number of elements in cluster)
and arrows aggregating connections between clusters (width proportional to number of connections). direction of
connections is preserved. (c): Heatmap displaying centrality measures for all nodes of the network. Darker coloring
indicates more central nodes. We consider four well-known centrality measures [29]: Katz centrality [18], eigenvector
centrality [19], betwenness centrality [20] and PageRank centrality [21].
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rank Gene Symbol Entrez ID Coefficient rank Gene Symbol Entrez ID Coefficient
1 PPP1R14A 94274 0.110724 32 CLEC2B 9976 -0.064569
2 NTN4 59277 0.105193 33 SCN3A 6328 0.064551
3 STMN2 11075 -0.099364 34 MEOX2 4223 0.063731
4 MEST 4232 0.099348 35 LYPD1 116372 0.062632
5 MMP3 4314 -0.096194 36 GREM2 64388 -0.061691
6 EPB41L3 23136 -0.086309 37 PTX3 5806 0.060865
7 COMP 1311 -0.083005 38 ANKRD1 27063 0.060542
8 SRGN 5552 0.081874 39 TSLP 85480 0.059524
9 HS3ST3A1 9955 -0.080812 40 HS3ST3B1 9953 -0.059407
10 NDUFA4L2 56901 0.080468 41 KCNE4 23704 0.05935
11 CCL2 6347 0.078802 42 MME 4311 -0.059128
12 SERPINB2 5055 0.078338 43 SLC16A4 9122 -0.058897
13 MXRA5 25878 -0.076091 44 RASD2 23551 -0.058538
14 TMEM158 25907 -0.074895 45 PRR15 222171 0.05832
15 SALL1 6299 -0.073901 46 STEAP1 26872 -0.058197
16 ITGA7 3679 0.07379 47 FOXS1 2307 0.058187
17 MAMDC2 256691 0.073285 48 IRX1 79192 -0.058006
18 PLPPR4 9890 0.072392 49 TMEM154 201799 -0.057991
19 F2R 2149 0.071678 50 CTHRC1 115908 -0.057906
20 ISLR 3671 -0.07022 51 LGALS3BP 3959 0.057905
21 VAT1L 57687 -0.070216 52 CNIH3 149111 -0.0574
22 DIRAS3 9077 -0.070214 53 S1PR1 1901 -0.057392
23 STEAP2 261729 -0.068838 54 EMX2 2018 -0.057108
24 PCDH10 57575 0.068817 55 CYP1B1 1545 0.05674
25 ZNF423 23090 0.06851 56 COL8A2 1296 -0.056338
26 MKX 283078 -0.068267 57 SFRP1 6422 -0.055354
27 ADGRF5 221395 0.067991 58 PRSS35 167681 0.055274
28 PLA2G4A 5321 0.067221 59 HAS2 3037 -0.05518
29 MYOCD 93649 0.066954 60 SOX9 6662 -0.054889
30 F2RL2 2151 0.065639 61 PLAT 5327 0.054882
31 JAG1 182 0.064746 62 SCN9A 6335 0.054334
Table 1: The 62 genes in the transcriptomic signature of HGPS and their associated coefficients. Genes are
ranked by the absolute value of their coefficient. A threshold of FDR = 10−4 was set using adjusted p-values
(Benjamini/Yekutieli method).
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GENEVESTIGATOR STRING
Anatomy co-exp. Cell lines co-exp. Perturbation co-exp.
SERPINH1 AHNAK EMP1 LMNB1
TRIP6 FAM129B FAM129B LMNB2
RRAS TNFRSF12A EIF4G1 UBC
TUBB6 MYOF FLNA RB1
array PTRF CD151 RNH1 RBB4
PRKCDBP LGALS3 ARHGDIA CTNNB1
FAM129B RHOC PLEC CASP6
EMP1 ANXA2 CD151 CASP2
MYOF CAPN2 MIR6836 SUMO1
CD151 RHBDF1 GNB2 EMERIN
RHOC PLEC ZYX CDK1
TSPAN4 ITGB5 CORO1C SYNE1
EHD2 SDC4 RHOC SUN2
RNH1 PHLDA2 EHD4 SVIL
FAM114A1 MVP MVP HIVEP1
PRSS23 ANXA2P2 ACTN4 YY1
P4HA2 S100A11P1 TAGLN2P1 CENPE
FRMD6 ITPRIPL2 MAP2K3 BRCA1
EXT2 FAM114A1 CD63 H2AFX
CTNNA1 KDELR3 AP1B1 SREBPF1
GNG12 NACC2 SEC61A1 PHB
ANXA2P2 YAP1 IER3
CCND1 GNG12 TUBB6
P4HA2 RRP12
EMP1 TMBIM1
Table 2: Genes in the immediate neighborhood of LMNA in functional (STRING) and gene co-expression networks
(GENEVESTIGATOR)
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GENEVESTIGATOR STRING
Anatomy co-exp. Cell lines co-exp. Perturbation co-exp.
TACC3 BUB1B BUB1B LMNA
NFYA KIF11 MCM10 MIS12
BORA TMPO SPC25 ZWINT
C1orf112 CCNA2 KIFC1 UBC
KNTC1 NASP CCNA2 CASP6
ZBED4 BUB1 UHRF1 SUN1
NCAPD2 NUSAP1 TTK SUN2
MIS18BP1 FAM72A CKAP2L SYCP1
BAZ1A FAM72B DTL SYCP2
APAF1 FAM72C UBE2C TEX12
GLE1 FAM72C PBK SYCE2
LBR FEN1 RAD51AP1 POT1
VRK1 HMGB2 TOP2A REC8
NCAPG2 GINS1 BUB1 SMC3
CASP2 DTL POLE2 H1F0
TMPO DEPDC1B RRM2 TINF2
HMGN2P41 MCM3 ASPM STAG3
FANCD2 MAD2L1 BIRC5 TERF2
CCNA2 NCAPH NUF2 CABIN1
RNF138 KIF18B CDK1 UBN1
PRPF38A CDCA5 AURKB HIST3H3
NDC80 CDK1 KIF20A HMGA1
TRA2A FANCD2 NCAPG2 UBE2I
CKLF-CMTM1,CKLF MND1 NDC80 TERF1
METTL21A HELLS HJURP ACD
CDC7 ASF1A
CENPA SMC1B
RP11-307P22.1 SYCP3
BRCA1
HIVEP1
TMPO
YY1
PRKCD
CDK1
H2AFX
Table 3: Genes in the immediate neighborhood of LMNB1 in functional (STRING) and gene co-expression networks
(GENEVESTIGATOR)
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GENEVESTIGATOR STRING
Anatomy co-exp. Cell lines co-exp. Perturbation co-exp.
CCNB1 KLF16 MCM2 CASP6
MIR7112 MIR7106 WHSC1 CASP2
PRC1 BAHD1 RNASEH2A LMNB1
RNASEH2A TRAIP RP11-298C3.2 YY1
MELK FZR1 MCM7 TMPO
FOXM1 AMBRA1 MCM4 PRKCD
SPDL1 GATAD2A MCM3 GPRASP2
TPX2 PLCB3 FEN1 SVIL
UBE2C WDR62 CDC20 HIVEP1
HMGA1 NCOA5 AURKB
CDC20 PPIAP21 CDC45
t DEPDC1 CWF19L1 FOXM1
PAICSP4 DHX37 UHRF1
TYMS TRMT61A MIR106B
KIF23 CCDC94 MIR93
CEP55 INTS5 MIR25
TRIP13 NELFB TIMELESS
DLGAP5 ZNF554 TRIP13
BUB1B SIRT6 UBE2C
NME1 DOHH BIRC5
UCK2 CASKIN2 CHEK1
DTYMK SUPT5H TPX2
KIF20A TOP3BP1 BUB1B
RP11-298C3.2 SLC25A22 KPNA2
CDC6 C20orf27 RP13-104F24.2
RP13-104F24.1
MCM5
POLD1
CTD-2545M3.6
SNRPF
Table 4: Genes in the immediate neighborhood of LMNB2 in functional (STRING) and gene co-expression networks
(GENEVESTIGATOR)
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Abstract
Physical connection between the nucleus and the cytoskeleton is essential for a broad range
of cellular functions. In this study, we developed an inducible HeLa Tet-On 3G cellular model to
investigate how the most common Lamin A mutation (Gly608Gly, Progerin) that causes HGPS im-
pacts on nucleus to cytoskeleton coupling. Altogether, our findings show that Progerin expression
significantly modifies the complex interaction between nucleus and the cytoskeleton. Promoting
Fascin phosphorylation at Serine 39 regulatory site results in a stronger Actin- Giant Neprin2 inter-
action. Moreover, in Progerin overexpressing cells the nuclear structure appears to be more rigid.
In addition, we have also investigated the effects of lamin A mutation on the cellular epigenetic
landscape. Our results revealed that Progerin presence influences Polycomb repressor complex 2
activity by preventing physiologic SUZ12 binding to the wild type form of Lamin A.
Introduction
Nuclear lamina (NL) is an evolutionary well conserved cell structure, present in all the Meta-
zoa [24]. It is a dense fibrillar protein meshwork that covers all the inner surface of the nuclear
envelope (NE). It mainly consists of A-type and B-type lamins, which are type V intermediate
filaments, and lamin-associated proteins (LAP) [11].
Besides providing mechanical support to the cells acting as nuclear framework, nuclear lamina
functions as scaffold for the binding of chromatin) [11] and interacts with several different proteins
related to the nucleoskeleton [8], the nuclear pore complex and factors whose role is to regulate
gene expression [40]. Therefore, lamins participate in almost all nuclear activities and all the fun-
damental cellular processes such as mitosis, cell signalling, mechanotransduction [8], proliferation,
and differentiation [13] [17].
The LINC (Linker of Nucleoskeleton and Cytoskeleton) complex consists of two major lamin-
interacting transmembrane proteins SUN1/SUN2 and Nesprin family proteins [30] [8]. SUN1
and SUN2 are inner nuclear membrane (INM) proteins that work as a bridge across the nuclear
envelope: while their amino-terminal domains interact with Lamin A on the nucleoplasmic face of
the NE, their carboxy-terminus binds to neprins in the perinuclear space (see Fig. 1). Nesprins
are high molecular weight proteins associated with the nuclear membrane (Fig.1). Four different
Nesprin proteins isoforms have been currently described: Nesprin-1, Nesprin-2, Nesprin-3 and
∗Caterina A. M. La Porta
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Nesprin-4. Nesprins can associate with the inner or outer nuclear membrane depending on their
size. In particular, the larger isoforms also called ”Giant”-Nesprin-1 and -2, associate with the outer
nuclear membrane exposing their N-term domain towards the cytoplasm where it binds cytoskeletal
microfilaments [41], intermediate filaments [42], actin-bundling proteins and microtubules [38]. In
particular, Nesprin-2 has been recently reported to recruit Fascin, an actin-bundling protein, to the
NE both in vitro and in vivo [34]. Fascin is made up of 4 b-trefoil repeats separated by short flexible
linker regions and it has 2 major binding sites for actin, one within the βt1-βt2 domains and the
second within βt3-βt4 [34]. Serine 39 (S39) on βt1 is an important regulatory site for the actin-
bundling activity of Fascin as its phosphorylation by PKCα results in Fascin binding to Nesprin-
2 promotion [34, 1]. More precisely, Nesprin-2 binds directly to the Fascin β-trefoil3 domain
through spectrin repeats (SRs) 5153 at its C-terminal domain, modulating nuclear localization
in fibroblasts and nuclear deformation in cancer cells [19]. In this way, Giant Nesprins ensure
nucleusto-cytoskeleton connection [16], providing a strong anchorage of the nuclear membrane to
the cytoskeleton that is essential for cell migration and correct localization of the nucleus inside
the cell. On the other hand, smaller Nesprins isoforms are present at the inner nuclear membrane
where directly bind to lamin A/C and Emerin, a nuclear envelope transmembrane protein involved
in NL-chromatin interaction [31].
In the last decades, hundreds of mutations in genes encoding for Lamins, in particular Lamina
A, or Lamins functional-related genes have been reported to be responsible for the onset of a range
of disorders, termed laminopathies. Laminopathies encompass apparently disparate phenotypes
with a broad clinical spectrum. Among these diseases, the most interesting one is Hutchinson-
Gilford Progeria Syndrome (HGPS) [36]. HGPS is an accelerating-aging genetic disorder due to
a point mutation in LMNA genes that leads to the production of an aberrant form of Lamina A
protein, lacking of 50 amminoacids, called Progerin [12]. Several studies reported that Progerin
persistence in HGPS has a dominant-negative effect on nuclear structure and functions, the most
noticeable defect being aberrant nuclear morphology [5, 15].
In this paper, we build up an inducible HeLa Tet-On 3G cellular model to investigate how the
most common Lamin A mutation (Gly608Gly, Progerin) that causes HGPS, modifies the shape of
the nucleus and why there is an impact from the functional point of view. Altogether, our data
clearly show that presence of Progerin modifies the complex interaction between nucleus and the
cytoskeleton and in particular increases the phosphorylated form of Fascin. The consequence of
this phosphorylation is that Fascin is more linked to giant Nesprin-2 and the nucleus appears more
rigid.
We have also investigated if under the expression of Progerin there is a different organization
of chromatin and lamins.
In fact, nuclear lamina has been widely reported to be involved in gene expression regulation,
and in particular in gene repression, since the discovery of lamin-associated domains (LADs)[22,
33]. LADs are heterochromatic and transcriptionally repressed large genomic regions marked
by H3K9me2, H3K9me3 or H3K27me3, that bind nuclear lamina [35]. the association between
NL and chromatin could be directly mediated by A-type lamins or indirectly by other lamins
functional related proteins such as Emerin. Emerin is a lamin-binding nuclear membrane protein
that has two distinct functional domains: the LEM-domain at the N-terminus, which mediates
binding to chromatin, and a second functional domain in the central region, which mediates a
direct binding to lamin A[23, 27]. Recent studies reported the presence of a strong functional
interaction between Lamin A and Polycomb complex group proteins (PcG) [29]. PcG proteins are
transcriptional regulators, mainly present in the nucleus as multimeric protein complexes named
Polycomb repressive complexes (PRCs)[6, 7]. The two complexes PCR1 and PCR2 are able to
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post-translationally modify histones and silence target genes acting as key epigenetic regulators
of the most important cellular processes. PRC1 and PRC2 have different roles: PRC2 imposes
high levels of H3K27me3 [3] as a repressive mark for chromodomains of PRC1, PRC1 recognizes
H3K27me3 and inhibits transcriptional elongation through H2A ubiquitylation [43] in order to
compact the chromatin structure [10, 14]. We characterized the PcG expressed under Progerin
expression observing no significant changes in protein expression levels. On the other hand, we
found that Progerin presence prevents the physiologic binding of SUZ12, a core component of
PCR2, to the Lamin A.
Material and Methods
Human Fibroblasts culture growth conditions
Human fibroblasts from HGPS patient (HGSDNF167) and the relatives of this patient (
HGFDNF168 and HGMDF090, father and mother, respectively) are obtained from the Proge-
ria Foundation Cell and Tissue Bank. The HGPS patient was a male of 8 years old with the
classical mutation (heterozygous LMNA Exon 11 c1824 C > T (p.Gly608Gly). The cells were
maintained according to the protocol reported by The Progeria Foundation: 15% FBS, DMEM
with 1% antibiotics and 1% L-glutamine. The cells were detached by trypsin EDTA 0.25% and
are maintained in culture for no more than five passages.
Plasmids and Subcloning
∆50-Lamin A plasmid was obtained by Addgene (pEGFP ∆50LaminA, Addgene, cod.17653).
Plasmid expressing pTRE3G-mCherry vector was obtained by Clontech (cod. 631165). E. coli
One Shot TOP10 bacteria (Invitrogen, C404006) were used for transformation with pEGFP
∆50LaminA and pTRE3G-mCherry vector. Competent cells were expanded and selected in Luria
Broth medium (Invitrogen, 12795-027) containing Kanamicin for pEGFP ∆50-Lamin A (Sigma
Aldrich, K13747) and 100 µg/mL Ampicillin (Sigma Aldrich, A5354 ) for pTRE3G-mCherry vector
for 18h 37◦C.
AfeI/BamHI fragment containing the coding reading sequence of ∆50 Lamin A was excised
by pEGFP-∆50LaminA plasmid (AfeI cod.R0652S, New England Biolabs) and subcloned into
pTRE3G-mCherry vector linearised with EcorV (cod. R1095S, New England Biolabs) and BamHI
(cod. R0136SS, New England Biolabs) restriction enzymes according to the manufacturer’s in-
structions. DNA fragments and vectors were routinely analysed by electrophoresis on 1% agarose
gel in 1X TAE (Euroclone GellyPhor EMR010100). Low Melting agarose gel (Euroclone Gellyphor
EMR911100) was used for the recovery of DNA fragments after electrophoresis. DNA fragments
were purified using agarose gels QIAquick Gel Extraction Kit. To recover DNA digested fragments
and linearised vectors after electrophoresis and proceed with subcloning, Promega T4 DNA ligase
(cod. M1801) was used to allow ligation step in according to manufacturer’s protocols.
DNA fragments and vectors were routinely analysed by electrophoresis on 1% agarose gel (Eu-
roclone GellyPhor EMR010100), in 1X TAE while Low Melting agarose gel (Euroclone Gellyphor
EMR911100) was used for the recovery of DNA fragments after electrophoresis. To purify DNA
fragments from agarose gels QIAquick Gel Extraction Kit was used. To recover DNA digested
fragments and linearised vectors after electrophoresis and proceed with subcloning, Promega T4
DNA ligase (cod. M1801, Promega) was used to allow ligation step in according to manufacturer’s
protocols. Promega PureYield Plasmid Miniprep and Midiprep (cod.A1330 and A2492, Promega)
were used to purify plasmidic DNA.
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Progerin Tet-On HeLa cells : transfection and culture methods
HeLa Tet-On 3G cells (Clontech cod. 631183 ) were cultured in DMEM (Euroclone cod.
ECB7501L) supplemented with 10% v/v Tet-free FBS (Euroclone, cod. ECS01821) 1% Penin-
cillin/Streptomycin and 1% L-Glutamine at 37◦C and 5% CO2 in humidified incubator immedi-
ately upon thawing without selective resistance. To create a double stable inducible HeLa 3G cell
line expressing ∆50 lamin A, HeLa 3G cells were co-transfected with 5µg of pTRE3G-mCherry-
∆50-Lamin A using Xfect reagent (Clontech, cod.631317) and 250 ng of puromycin linear selection
marker (Clontech cod.631626) in according to the manufacturer’s instructions.
After 48h post-transfection, the cells were splitted into 4 x 10cm dishes and 0,5 µg/ml of
Puromycin (Life Technologies cod. A11138-03 ) and 200µg/ml G418 (Sigma, cod. A1720) was
added to select the positive clones. Drug-resistant colonies appeared 2 weeks after selection. Single
clones were isolated using cloning cylinder (Sigma cod. C1059). When they reached the confluence,
the cells were splitted in 6-well plate for testing the expression of ∆50 lamin A and for further
maintenance. In order to express ∆50-Lamin A in dose dependent manner, the cells were induced
with doxycycline (Clontech cod.631311) at the concentration indicated in the figures and analysed
48h after the induction. HeLa 3G cells expressing ∆50-Lamin A were rountinely maintained in
culture in DMEM (Euroclone cod. ECB7501L) supplemented with 10% v/v Tet-free FBS (Eu-
roclone cod.ECS01821), 200µ/ml G418 and 0.25µg/ml Puromycin, 1% Penincillin/Streptomycin
and 1% L-Glutamine at 37◦C and 5% CO2.
∆50 lamin A and WT lamin A transient trasfection
Plasmid containing the human Lamin A-C-18 (Addgene, cod. 55068) or Progerin (pEGFP-
∆50 lamin A, Addgene, cod.17653) were purchased by Addgene. E. coli One Shot TOP10 bac-
teria (Invitrogen, cod.C404006) were transformed with plasmids, expanded and selected in Luria
Broth medium (Invitrogen, cod. 12795-027) containing 50 µg/mL Kanamicin. PureYield Plasmid
Miniprep and Midiprep (Promega, cod.A1330 and A2492) were used to purify plasmidic DNA.
HeLa cells were maintained in DMEM (Euroclone, cod. ECM0060L) medium with 10% fetal
bovine serum ( Euroclone, ECS0180L), 100 U/ml penicillin, 100 mg/ml streptomycin sulphate
(Euroclone,cod. ECB3001D) and 2mM L-Glutamine ( Euroclone, cod. ECB3000D-20) at 37◦C in
an atmosphere of 5% CO2 and 95% humidity. Cells seeded at an 70% confluent onto 6-well plates
were transiently transfected with pEGFP ∆50LaminA (Addgene, cod.17653) or mEmerald-WT-
LaminA (Addgene, cod.54139) using Xfect transfection reagent (Clontech, cod 631317). After 48
h from transfection cells were used for cytosckeleton pharmacological perturbation experiment (see
Materials and Methods).
Immunofluorescence
Subconfluent cells grown on glass coverslips are fixed with ice cold methanol for 5 minutes at
-20◦C, permeabilized and blocked with 1% BSA /10% Goat Serum/0.3M glycine/0.1% Tween 20
in PBS for 1 hr at room temperature.
The cells are stained with anti-Panlamin (1:50 mouse, Abcam ab207404) or anti-Lamin A
(1:100 mouse, Abcam ab8980) or anti-Lamin B1( 1:200 rabbit, Abcam ab16048) or Anti-Progerin
overnight at 4◦C. Thus, after a brief washing with PBS, the cells are incubated with the secondary
antibody (anti rabbit or anti-mouse Alexa488 1:250) for 1 h. The nuclei are counterstained with
DAPI and the slides mounted with Pro-long anti fade reagent (Life technologies). The images are
acquired with a Leika TCS NT confocal microscope.
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Duolink assay
Duolink assay involve a pair of oligonucleotide labeled secondary antibodies (PLA probes) that
generates a fluorescent signal when the two PLA probes, bound to two primary antibodies raised
in different species, recognized two antigens in close proximity (less than 40nm). Subconfluent cells
were fixed on slides with ice cold 100% methanol for 5 min at at -20◦C and incubated with Duolink
Blocking Solution for 60 minutes at 37◦C in a humidity chamber. Slides were then incubated in a
humidity chamber overnight at 4◦C with Lamin A (1:100 Abcam mouse, ab8980) or Panlamin (1:50
mouse, Abcam ab207404) and SUZ12 (1:800, Rabbit mAb 3737, Cell Signaling) or BMI1 (1:600,
Rabbit mAb 6964, Cell signaling ) antibodies were diluted in the Duolink Antibody Diluent and
the slides were incubated with antibodies solution in a humidity chamber overnight at 4◦C. After
washing, anti-rabbit PLUS and anti-mouse MINUS PLA probes were diluted 1:5 in the Duolink
Antibody Diluent and samples were incubated in a pre-heated humidity chamber for 1 hour at
37◦C.
Ligation and amplification steps were performed according to manufacturer’s instructions.
Slides were mounted with Duolink In Situ Mounting Medium with DAPI (DUO82040, Sigma-
Aldrich). The images were acquired with a Leika TCS NT confocal microscope.
Western blot
Confluent cells were lysed by boiling in a modified Laemmli sample buffer (2% SDS, 20%
glycerol, and 125 mM Tris-HCl, pH6.8). The protein concentration was measured by DC Protein
Assay Kit (BioRad). Equal amount of proteins were loaded on gel, separated by SDS-PAGE and
transferred to a PVDF membrane (Trans-Blot Turbo ini PVDF, BioRad) using Trans-blot turbo
system (BioRad). After blocking with 5% BSA/0.1% Tween20 in PBS for 1h at RT, primary and
HRP-linked secondary antibodies specific bindings were detected by chemiluminescence system
(Clarity Western Blotting ECL substrate, Biorad).
Mouse monoclonal antibody anti-nesprin 2 (1:1000, MABC86 ) or rabbit anti-SUN1 ( 1:1000,
Abcam ab103021) or anti-Emerin (1:200 rabbit, Abcam ab40688) or anti-SUZ12 (1:1000, Rabbit
mAb 3737, Cell Signaling) or rabbit anti- Ezh2 (1:1000, Rabbit mAb 5246 , Cell Signaling) or
rabbit anti- Ring1A (1:1000, Rabbit mAb 13069, Cell signaling) or rabbit anti-RING1B (1:1000,
Rabbit mAb 5694, Cell Signaling) or rabbit anti- Bmi1 (1:1000, Rabbit mAb 6964, Cell signaling)
or rabbit anti- H3K27met3 ( Rabbit mAb 9733, Cell signaling) were used overnight at 4◦C.
Mouse anti-vinculin (1:10000, V9264, Sigma) or rabbit anti-GAPDH( 1:5000, Sigma G9545) or
Anti β-tubulin (1:5000mouse, Sigma T0198) for 1h at room temperature was used as housekeeping.
Secondary antibodies ( anti-rabbit or anti-mouse-HRP 1:3000 in 5% milk/0.1% Tween20 in PBS,
Biorad) were used for 1h at room temperature to detect chemiluminescence.
Fascin immunoprecipitation with Protein A-Agarose
Confluent cells weere detached from the culture plates using a cell lifter in cold PBS, collected
in a 1,5 ml eppendorf and the cell suspension was centrifuged at 3.5·103 x g for 5 min at 4◦C.
Cell pellets were resuspended in lysis buffer (2 mM EGTA,0.5 mM EDTA, 0.5 mM PMSF, 1X
TRITONX100, 1X protease cocktail Sigma Aldrich P8340) and incubated on ice for 30 min with
periodic agitation. The lysate was centrifuged at 14·103xg for 10 min at 4◦C, the supernatant
transferred to a fresh tube and proteins concentration was measured by DC Protein Assay Kit
(BioRad). 500 µg of total proteins in lysis buffer were incubated with anti-fascin antibody (1:100,
AbCam, ab126772) overnight at 4◦C under agitation and following 50% beads slurry of Protein
A-Agarose (Sigma-Aldrich, P9269) was added to the lysate. The mixture of beads and lysate was
incubated with gentle rocking for 2 hours at 4◦C and then centrifuged at 14·103 x g for 10 min
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at 4◦C. After three washes with 500µl of lysis buffer the sample was resuspended in 30µl of 2X
Laemmli sample buffer(2% SDS, 20% glycerol, and 125 mM Tris-HCl, pH 6.8).
Finally, samples were heated to 90◦C for 5 minutes. 15 µl per sample were loaded on SDS-
PAGE gel (7.5%) and transferred to a PVDF membrane using Trans-blot turbo system (BioRad).
After blocking with 5% BSA/0.1% TWEEN20 in PBS for 1h at RT, anti Phospho-Fascin antibody
(1:10000, Abcam ab90618) or anti-fascin antibody (1:100, AbCam, ab126772) and HRP-linked
secondary antibody specific bindings were detected by chemiluminescence system (Clarity Western
Blotting ECL substrate, Biorad).
Cytosckeleton Pharmacological Perturbation
To study the role of cytoskeleton in this context, actin and myosin organization were perturbed
by exposing pEGFP-∆50LaminA or mEmerald-WT-LaminA overexpressing cells to Blebbistatin,
a myosin inhibitor, or to a cell-permeable inhibitor of formin-mediated actin nucleation and formin-
mediated elongation of actin filaments, SMIFH2. Subconfluent Hela cells expressing WT or ∆50
Lamin A were exposed to 25µM Blebbistatin (Sigma-Aldrich, B0560) for 30 min or to 20µM
SMIFH2 (Sigma-Aldrich, S4826) for 1 hour at 37◦C and 5% CO2 in humidified incubator. Five
minutes prior the end of the treatment, Hoechst (1:1000, Life technology, H3570) was added to
the cell medium to counterstain nuclei. Immediately after the end of each treatment, medium
containing drugs was replaced with fresh medium and cells were time-lapse imaged (1 shoot every
15 minutes) for 1h using a Leica TCS NT confocal microscope (63X) with a z-stack of 0.5 µm.
Image analysis
Immunofluorescence images were analyzed using existing and customized ICY plugins (v.1.9.4
and 1.9.5 [9]) and custom python scripts. In all the analyzed frames nuclei close to the borders or
superimposed were manually discarded.
Duolink assay analysis. Reconstruction of nuclear envelope was performed on all the Z-stacks with
ICY Icy HK-Means and ActiveContour plugin using DAPI signal and the resulting 3D meshes were
exported as VTK files. A wide range of parameters was explored in order to ensure that our result
were not affected by the specific parameters chosen for reconstruction. Duolink spot recognition
was performed separately on each nucleus with a semi-automatic protocol involving HK-means
tresholding (ICY Thresholder plugin). The minimum size of each accepted spot was set to 70 px.
Center of mass (CM) was used to determine the relative position of the duolink spot respect to
the nuclear envelope, and spots inside reconstructed nuclear mesh were counted.
Cytosckeleton Pharmacological Perturbation analysis. Reconstruction of nuclear envelope was per-
formed on all the Z-stacks was performed using images with the nuclei and over-expressed lamin
skeletons. We applied the Icy HK-Means plug-in to obtain three dimensional (3D) nuclear re-
gions of interest (ROIs) for each temporal acquisition. This segmentation method uses, in fact,
a K-Means classification to detect clustered objects corresponding, in our case, to the nucleus
structures. The final 3D meshes of the outer nuclear membrane have been obtained thanks to
the Icy Active Contours plug-in. The parameters used for the reconstruction are the default ones
except for the values of contour smoothness, contour sampling and region sensitivity. For these
three parameters we used, respectively, the values in the ranges 0.028-0.032, 1.9-2.1 and 2-3.
Total volume change between two meshes M0, M1 of a given cell at different time-points can
reveal key information in some situations, but most local morphological changes can take place
at fixed volume. To circumvent this issue and detect local morphological changes, we develop the
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concept of local displacements dj, which can be interpreted as the distance each face of M0 should
move to turn M0 into M1.
Briefly, the local displacements dj of a triangular face j of a mesh M0 with respect to a mesh
M1 are computed as follows. We find the matching µ that minimizes the total distance:
µ = argminm
∑
i
||m(vi)− vi|| (1)
where m : V0 → V1 is a one-to-one correspondence between the vertices of M0 and those of M1. If
|V0| 6= |V1|, we resort to subsampling the mesh with the largest number of vertices. We solve the
equation using the Hungarian algorithm as implemented by the scipy.optimize.linear sum assignment
function from the SciPy library . We computed the displacement vectors ~qi = µ(vi) − vi of each
vertex, the normal vectors to all faces ~nj and the projections of qi on nj. The local displacement
dj is the average of qi · nj over the vertices i that form face j:
dj = ~nj ·
(
1
3
2∑
i=0
~qi
)
(2)
For each cell, the standard deviation σ(d) of local displacements dj over all the faces can be
used as a proxy of deformation. Large values of σ(d) are associated with heterogenous morpho-
logical changes such as bleb formation, while low values of σ(d) are obtained when the changes
are homogenous over the nucleus surface. In particular, volume changes due to a uniform shrink-
ing/expansion would entail a value of σ(d) 1.
Results
Progerin expression in TetON HeLa cells
We have developed a ∆50-Lamin A inducible expression HeLa model using Tetracycline con-
trolled gene activation system (Tet-On system). Tetracycline controlled transcription activation is
a method of inducible gene expression where transcription is reversibly turned on or off depending
on the presence of the antibiotic tetracycline. Briefly, we cloned ∆50-Lamin A insert under the
control of tetracycline inducible promoter (TRE3G), that only in presence of Doxycycline (Dox),
a tetracycline analogous, promotes ∆50-Lamin A transcription in a Dox dose-dependent manner.
In Figure2 is shown ∆50-Lamin A expression increase with increasing in Dox concentration,
after 48h of exposure. As appreciable, we achieved a significant increase of Progerin expression
levels at 10 ng/ml of Dox, that resulted to be best experimental condition since allow us to
completely avoid Dox off-target effects, such as aspecific Progerin fluorescent signal observed in
cells exposed to 20 ng/ml Dox (Fig.2b). Notably, 48h after Progerin expression induction with
Dox 10 ng/ml, we observed the presence of dysmorphic nuclei displaying a cellular phenotype
very similar to those of HGPS derived cells (Fig.2c). Therefore, at least for the morphological
point of view, our model faithfully resembles pathologic cell morphology. For all the subsequent
experiments we used the induction with 10ng/ml Dox. Then, we have checked the levels of Lamin
A and Lamin B in Tet-On expressing Progerin HeLa. As shown in Figure 3, no significant changes
occur for both Lamin A and Lamin B at all the concentration of Dox.
Impact of Progerin on Lamina-Cytoskeleton interactions
Cell nucleus is not to be considered an entity by itself, detached from the context in which it
resides. Indeed, it is physically and thus functionally connected both with the cytoskeleton via
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nuclear lamina components and linkers proteins interactions, and with the residing DNA via lamins
and Nuclear envelope transmembrane proteins (NETs) indirect bindings. In order to evaluate
the impacts of Progerin expression on the complex protein network that ensure nuclear lamina
connection both with extranuclear compartment and chromatin, we investigate the expression of
one the most important NET protein, Emerin that mediates nuclear lamina-chromatin binding, and
LINC complex components, SUN1 and Nesprin2, responsible for nucleus-cytoskeleton coupling.
As shown in Figure 4, no significant changes in the expression of both Emerin and SUN1 occur in
HeLa Tet-On Progerin-expressing cells. Nesprins are transmembrane proteins associated with the
nuclear membrane [19, 39], belonging to the LINC complex. In particular, the larger isoforms called
giant-nesprin-2 [21], associate with the outer nuclear membrane exposing their N-term domain
towards the cytoplasm where it binds cytoskeletal actin and their C-term domain towards the
perinuclear space where it binds to SUN1/2. In Figure 4 is shown that the level of expression
of Giant-nesprin 2 does not change in Tet-On expressing Progerin HeLa cells. Considering that
nesprin- 2 interaction with actin is regulated by phosphorylated ser39 fascin [19], we checked by
immunoprecipitation the status of phosphorylation of Fascin in ser39. Interestingly, we found an
increase of fascin serine 39 phosphorylated in Tet-On expressing Progerin HeLa cells (Fig.4, panel
b). This data suggests a more stable coupling between the nucleus and cytoskeleton in the presence
of Progerin.
Effect of Progerin on morphological changes due to drug targeting cytoskeleton
To better understand the possible functional changes due to the expression of Progerin in
HeLa cells we transiently transfected these cells with GFP-∆50 Lamin A (Progerin) or GFP-
WT Lamin A plasmids and then we treated the cells with two different drugs which act on the
cytoskeleton: blebbistatin, a myosin inhibitor [25] and SMIFH2, an inhibitor of formin-mediated
actin nucleation [18] for 30min and 1h, respectively. After each treatment, we put the cells in fresh
drug-free growth medium and we took a snapshot with a confocal microscope in time lapse of the
cells treated or untreated, every 15 minutes up to an hour. The nucleus 3D mesh has been then
reconstructed with Icy according to Material and Methods section.
Figure 7 shows distribution of nuclear envelope displacement standard deviation that is an
indicator of nuclear deformation as function of the time, after actin or myosin inhibitors exposure
and in untreated cells. As shown in Figure 7a, the treatment with blebbistatin significantly inhibits
the physiological nuclear fluctuations in cells expressing Progerin with respect to untreated cells.
In contrast, a negligible effect occur in cells expressing wt Lamin A (Fig.7a). Similar results occur
with SMIFH2 treatment (Fig.7b) All together, these results suggest that the cell nuclei of Progerin-
overexpressing cell are more rigid/stiffer and less plastic in comparison with those overexpressing
WT Lamin A. Moreover, our data seem to indicate that in ∆50 Lamin A overexpressing cells
nuclear fluctuations are mainly dependent on cytoskeleton coupling, since cytoskeleton components
pharmacological inhibition results in a complete suppression of nuclear physiological fluctuations
in time.
Expression of Prgerin prevents Polycomb Repressor Complex 2 binding to Lamin A
Nuclear lamina can be considered a regulator of chromatin status and thus gene expression
since it works as dynamic platform that binds residing DNA, a large number of transcription
factors and epigenetic regulators such as Polycomb complex group proteins (PcGs). In order to
investigate the impact of Progerin overexpression on cellular epigenetic landscape, we analysed
the expression levels of PcG proteins in our cellular model. In particular, we evaluated whether
Progerin presence interferes in PcG protein-nuclear lamins interaction.
43
First we characterized the level of expression of the main PcGs in TetON Progerin expressing
HeLa cells. As shown in Figure 8, we found that these cells express the main important PcGs.
Then, we performed a proximity ligation assay which allows the detection of a fluorescent spot
if two different primary are in close proximity (less than 40 nm), such as when they bind one to
another.
Figure 9 shows the quantification of the number of dots obtained with proximity ligation assay.
While there is no significant changes in the number of dots between PanLamin or Lamin A bindings
BM1 In contrast, we found a significant decrease in the number of dots between PanLamin A and
SUZ12 with respect to Lamin A and SuZ12 (Fig.9b).
Discussion
Nuclear lamina is involved in almost all fundamental cells functions since it is a dynamic
platform that, besides providing mechanical support to the nucleus, takes contacts with a large
number of proteins with different functions, termed lamin-associated proteins (LAP), and the
residing DNA [37]. Mutations in lamins and lamin-associated proteins cause human diseases
termed laminopathies [4]. Among these, there is the premature ageing disease HGPS, whose most
prominent feature is the presence of aberrant nuclei. Progeria patients derived cells might be, in
principle, the best biological tool to study in vitro the impact of Progerin on nuclear architecture
and functions. Unluckily, these primary cells are not researchers friendly since these are obtained
from very rare bioptic samples, have a very slow rate of doubling and can be maintained in culture
for very few passages. The canonical approach used to bypass these experimental problems, is
building cellular models that try to mimic the pathologic condition by overexpressing or silencing
Lamin A or Progerin. This kind of models, although informative, most of the time are exasper-
ation of the reality. Thus, in order to perturb nuclear lamina architecture in a more controlled
way, with fine tuning of gene expression, we developed a Progerin-inducible expression cellular
model using Tetracycline controlled gene activation system (TetOn system). Our model resembles
the typical morphological changes of HGPS nuclei: under Progerin induced expression, indeed,
we observed the presence of dysmorphic, disrupted, blebbed nuclei very similar to those of HGPS
patients derived cells. One of the prominent structural role of NL consists in the formation of a
physical and functional link between the lamina and the cytoskeleton [8]. These links, fundamental
for the proper nuclear positioning in the cell and for mechanotransduction processes, are mediated
by Lamin A and SUN 1/2 at the inner nuclear membrane, and SUN1 and Giant nesprin 1/2 in
the perinuclear space [28]. Giant Nesprin-1/2 association with actin [41] is mediated by Fascin, an
actin bundling-protein, whose phosphorylation at S39 by PKCα promotes its binding to Nesprin-
2 [34, 1]. Notably, nuclear envelope localized Fascin has been reported to be crucial in maintaining
the nuclear morphology and it allows nuclear deformability in physiologic conditions [19]. Our
data clearly show that, the expression of progerin in TetOn Hela cells does not induce any sig-
nificant changes in the level of expression of SUN1, emerin and Giant Nesprin2 expression, but
promotes the phosphorylation of Serine-39 residue of Fascin. Therefore, this data suggest that
the nucleus is more tightly linked to the cytoskeleton in the presence of progerin. Confirming this
view, we found that progerin expression reduced the capability of the nucleus to ripristinate its
morphology after inhibition of the cytoskeleton by blebbistatin or SMIFH2. Therefore in addition
to the reported importance of the ratio of A-type lamins and B-type lamins for nuclear stiffness
and plasticity [26], Progerin also contributes to the rigidity of the nucleus in agreement with other
evidences [2]. Finally we checked the possible effect of progerin on the interaction between Poly-
comb group complex proteins (PgC). PcG proteins are transcriptional regulators that associate in
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multimeric complexes termed Polycomb repressor complex 1 and 2 [6, 7]: key epigenetic regulators
that post-transcriptionally modify histones leading to chromatin compactation [10, 14]. It has
been reported that PcGs directly bind to Lamin A [29]. Moreover, the reduction of Lamin A/C
levels causes PcGs dispersion in the nucleoplasm, accompanied by a relaxation of PcG-mediated
higher-order chromatin structure which become more prone to transcriptional reactivation [29]. In
progerin expressing cells we found an interesting decrease of LaminA-Suz12 interaction. Suz 12 is
a core component of PCR2 that is required for an efficient H3K27 methylation [32]. Therefore,
we speculate that the reduction of Suz12 and Lamin A interaction observed in the presence of
progerin might contribute to the widely reported heterochromatin loss observed in HGPS derived
cells [20]. Altogether, our findings revealed the peculiar role of Progerin in the changes of mechan-
ical interaction between lamins and the cytoskeleton and in epigenetic regulation of chromatin
status.
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Figures
Figure 1: Schematic representation of Nuclear membrane outer.
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Figure 2: Panel a) Western blot of Progerin in HeLa TetON Progerin-expressing cells exposed to increasing dose of
Dox. 20µg total protein were loaded on 10% polyacrylamide gel, transferred on PVDF and incubated with rabbit
anti-Progerin (1:1000 rabbit, Abcam ab66587) overnight at 4◦C. Mouse anti-Vinculin antibody (1:5000, Sigma)
for 1 h at room temperature was used as housekeeping. Panel b) Progerin expression of HeLa TetON Progerin-
expressing cells. Subconfluent cells were fixed with ice-cold methanol and incubated with anti-Progerin (1:20 rabbit,
Abcam ab66587) overnight at 4◦C. Then, the cells are incubated with anti-rabbit AlexaFluo488 for 1 h, at room
temperature. Nuclei are stained with DAPI. Images are acquired by Leica SP2 laser scanning confocal microscope.
Panel c) Example of HeLa TetON Progerin-expressing cells morphology before Dox induction, after 48h of Dox-
Progerin induction and a HGPS derived cell. Subconfluent were cells fixed with ice-cold methanol, incubated with
anti-PanLamin (1:50 mouse, Abcam ab207404) at 4◦C and following with anti-mouse AlexaFluo488 for 1 h, at room
temperature.
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Figure 3: Lamin A and B in TetON expressing Progerin HeLa cells Western blot of Lamina A and Lamin
B in HeLa cells untreated and after 2 days of increasing dose of Dox exposure. 20µg total protein were loaded on
10% polyacrylamide gel, transferred on PVDF and incubated or anti-Lamin A (1:1000 mouse, Abcam ab8980) or
anti-Lamin B (1:1000 rabbit, Abcam ab16048) overnight at 4◦C. Mouse anti-Vinculin antibody (1:5000, Sigma) for
1 h at room temperature was used as housekeeping.
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Figure 4: Levels of expression of Emerin and SUN1 in ∆50-laminA inducible cellular model after Progerin induced
expression (10 ng/ml Dox) and in control condition. Western blot of Emerin (panel a) and SUN1 (panel b) in
HeLa TetOn Progerin expressing cells. 20 µg total protein were loaded on 10% polyacrylamide gel, transferred on
PVDF and incubated with anti-SUN1 (1:1000, Abcam ab103021) or anti-Emerin (1:1000 rabbit, Abcam ab40688)
overnight at 4◦C. Rabbit anti-GAPDH( 1:5000, Sigma G9545) or mouse anti β-tubulin (1:5000, Sigma T0198) for
1h, at room temperature was used as housekeeping. Secondary antibodies (anti-rabbit or anti-mouse-HRP 1:3000
in 0.1% Tween20 / 5% milk in PBS, Biorad) were used for 1h at room temperature to detect chemiluminescence.
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Figure 5: Giant Nesprin-2 and S39-P-Fascin expression levels in ∆50-laminA inducible cellular model.
Western blot of Giant-Nesprin2 in HeLa TetOn Progerin expressing cells. 20 µg total protein were loaded on 10%
polyacrylamide gel, transferred on PVDF and incubated with mouse monoclonal antibody anti-nesprin 2 (1:1000,
MABC86 ) overnight at 4◦C. Mouse anti β-tubulin (1:5000, Sigma T0198) for 1h at room temperature was used as
housekeeping. Secondary antibodies (anti-mouse-HRP 1:3000 in 5% milk/0.1% Tween20 in PBS, Biorad) was used
for 1h at room temperature to detect chemiluminescence.
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Figure 6: Western blot of S39-P-Fascin in HeLa TetOn Progerin expressing cells. 500 µg of total proteins were
incubated with anti-Fascin antibody (1:100, Abcam ab126772) overnight at 4◦C under agitation and following
immune-precipitated with Protein A-Agarose (Sigma-Aldrich) beads. 15µl of immunoprecipitated protein solution
per sample were loaded on SDS-PAGE gel (7.5%) and transferred to a PVDF membrane using Trans-blot turbo
system (BioRad). After blocking with 5% BSA/0.1% TWEEN20 in PBS for 1h at RT, anti Phospho-Fascin antibody
(1:10000, Abcam ab90618), anti-Fascin (1:1000, Abcam ab126772) and HRP-linked secondary antibody specific
bindings were detected by chemiluminescence system (Clarity Western Blotting ECL substrate, Biorad).
49
Figure 7: Fluctuations of local displacements σ(d) over time for WT and ∆50 Lamin A overexpressing
cells. Cells were treated with the myosin inhibitor, Blebbistatin (a) or actin an inhibitor of formin-mediated actin
nucleation, SMIFH2 (b) for 30 min and 1h respectively. At the end of treatment, cells returned in routinely fresh
growth medium and imaged every 15 min, for 1h. Timepoint i refers to local displacements from time point i− 1
to time point i. Time points are taken for 1h, every 15 minutes, after the end of both treatments. Statistical
significance is assessed through a Kolmogorov-Smirnov test at the significance level of α = 0.01. (c) Representative
images of nuclear reconstruction in all the analyzed experimental condition.
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Figure 8: Western blot of PcG protein expression in HeLa TetOn Progerin expressing cells. 20 µg total protein
were loaded on 10% polyacrylamide gel, transferred on PVDF and incubated with anti-SUZ12 (1:1000, Rabbit mAb
3737, Cell Signaling) or rabbit anti- Ezh2 (1:1000, Rabbit mAb 5246, Cell Signaling) or rabbit anti- Ring1A (1:1000,
Rabbit mAb 13069, Cell signaling) or rabbit anti- Bmi1 (1:1000, Rabbit mAb 6964, Cell signaling), overnight at
4◦C. Mouse anti-vinculin (1:10000, V9264, Sigma) or rabbit anti-GAPDH (1:5000, Sigma G9545) or Anti β-tubulin
(1:5000mouse, Sigma T0198) for 1h at room temperature was used as housekeeping. Secondary antibodies (anti-
rabbit or anti-mouse-HRP 1:3000 in 5% milk/0.1% Tween20 in PBS, Biorad) were used for 1h at room temperature
to detect chemiluminescence.
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Figure 9: Quantification of the number of foci per cell identifying lamins and BMI1 or SUZ12 inter-
actions. Number of dots per cell was estimated using customized ICY pipeline [9]. Progerin induction (Dox 10)
does not influence BMI1 interaction with the lamins (a). At the opposite, we can observe slight decrease of dots
SUZ12-Panlamin dots and a significative decrease of interactions for SUZ12-Lamin A (panel b, *** p-value ¡0.01,
assessed through a Kolmogorov-Smirnov test).
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Abstract
A delicate balance of reactive oxygen species (ROS) exists inside the cell: when the mechanisms
that controls the level of ROS fail, the cell is in an oxidative stress state, a condition that can help
aging processes. To contrast the pro-aging effect of ROS, the supplementation of antioxidants has
been recently proposed. Sulforaphane (SNF), is an isothiocyanate isolated from Brassica plants
that has been shown to modulate many critical factors inside the cells that seems to help in
contrasting aging. In the present work, we have used a short, subletal and repeated exposure for 8
days to hydrogen peroxide without or in combination with low concentration of low concentration
of SNF in human dermal fibroblasts. Hydrogen peroxide treatments do not affect the oxidative
status of the cells, without any significant change of the intracellular ROS levels or the number of
mitochondria or thiols in total proteins. However, our regime promotes cell cycle progression and
cell viability, increases the anti-apoptotic factor survivin, decreases Lamin B and increase DNA
damage, measured as number of foci positive for γH2AX. Therefore this kind of treatment, despite
the fact that the oxidative status of the cells appears to be restored, is able to alter the delicate
balance of the cells helping DNA damage. On the other hand, the treatment with SNF alone
does not affect significantly the cells and seems to exert a protective effect increasing the level of
p53 than can block the expansion of possible DNA damaged cells. However, continuos exposure to
SNF is not able, at this concentration, to protect cells against hydrogen peroxide induced oxidative
stress.
Keywords: oxidative stress, sulforaphane, fibrobalsts, lamins
Introduction
Senescence is a complex process where the integrity and the structure of the nuclear scaffold
changes [1]. The nuclear envelope involves a complex network of intermediate filaments including
Lamina A/C and Lamin B which affect chromatin architecture and topology of chromosomal do-
mains [2]. One important factor contributing to cell senescence is oxidative stress [3]. Reactive
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oxygen species (ROS) are physiological by-products of mitochondria metabolism. Oxidative stress
is due to the level of reactive oxidative species (ROS) produced by the cells that could cause
damage at the level of DNA, membrane lipids and proteins. ROS level regulates physiological
functions, including signal transduction, gene expression, and proliferation, therefore they under-
line physiological and pathological events [4]. For example, mitochondrial ROS may activate an
adaptive response which promotes health to extend the lifespan through diseases prevention [5].
ROS overproduction, on the other hand, hampers damaged nuclear and mitochondrial DNA repair
at multiple steps, contributing to cell genomic instability [6]. Interestingly, ROS, including hydro-
gen peroxide, can inhibit cell growth and induce cell death and senescence in a context-dependent
manner [7]. Accordingly, a recent paper showed that low levels of ROS can improve the defense
mechanisms by inducing adaptive responses, which in turn contributes to stress resistance and
longevity [8]. In contrast, high levels of ROS induced insufficient adaptive responses, contributing
to aging onset and progression [8]. Interventions to keep low the level of ROS, by both scavenging
free radicals and enhancing antioxidant factors, are widely proposed as an anti-aging state.
The main goal of the present paper was to investigate the impact of short and repeated sublethal
treatments with hydrogen peroxide, commonly used to mimic oxidative stress [3], alone or in
combination with sulforaphane (SFN) on human primary dermal fibroblasts (hSDF) focusing on
critical biological functions of the cells. Recent evidence in fibroblasts showed that concentrations
between 90-360µM of hydrogen peroxide is sufficient to induce oxidative stress and premature
cellular senescence in vitro, recapitulating an aging process profile [3]. SNF is a well tolerate natural
compounds obtained from cruciferous vegetables which has been shown to have a protective effect
on the cells through Nrf2-mediated induction of phase 2 detoxification enzymes that elevate cell
defense against oxidative damage and promote the removal of potential carcinogens [9]. However,
it is becoming clear that multiple mechanisms are activated in response to SFN, including the
suppression of cytochrome P450 enzymes, the induction of apoptotic pathways, the suppression of
cell cycle progression, the inhibition of angiogenesis and anti-inflammatory activity [9]. Another
important biological activity of SFN is the negative control of HDAC activity [9].
Altogether, our findings show two interesting aspects: first low and pro-longer exposure with
sublethal stress of hydrogen peroxide leads to a significant decrease of Lamin B expression and the
treatment with SNF is able to contrast this effect. Long treatment with SNF alone increases p53
level of expression suggests that alone it plays a protective role inside the cell versus DNA damage
to DNA. However, this is not sufficient to protect against hydrogen peroxide, since DNA damage
occurs in cells treated with both SNF and hydrogen peroxide.
Results
Effect of short and repeated sublethal treatment with hydrogen peroxide without or in combination
with SNF on the oxidative status of hSDF cells after 8 days
H2DCFDA is a chemically reduced form of fluorescein used as an indicator for reactive oxygen
species (ROS) in cells. The short treatment (30min) with hydrogen peroxyde repeated 48 h for 8
days with sublethal concentrations (15µM or 25µM of H2O2) (see Fig. S1) according to [3] alone
or in combination with 1µM SNF does not affect the levels of ROS measured using H2CDF assay
or the numbers of mitochondria quantified by flow cytometry (Fig.1). These data suggests that
during the 48 h recovery, the cells are able to recover possible damages.
It is known that oxidative stress leads to the formation of unwanted disulphide bonds in the
cytoplasm resulting in protein folding leading to the end to impair proteins function. To face this,
the cells have several mechanisms to increase the intracellular levels of thiol[10]. Notably, It has
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been recently reported that the intracellular increased of thiols are strongly associated with an
increased tolerance to an oxidant stress [10] since they act as extraordinarily efficient antioxidants
protecting the cells against consequences of damage induced by free radicals [11]. Conversely,
large increase in free thiols on the circulation are associated with toxic effects [12]. Under our
experimental conditions, the levels of reduced thiols in total proteins measured by biotin maleimide
assay, do not show any significant changes (Fig. 1).
SNF and oxidative stress decrease cell viability but promote cell cycle progression and regulation of
apoptosis
The short treatment (30min) with H2O2 repeated 48 h for 8 days with sublethal concentrations
(15µM or 25µM) (see without or in combination with SFN Fig. S1), promotes cell cycle progression
as shown Fig. 2a. In fact, we detected an increase in the number of cells into G2-M phase (Fig.
2a). On the other hand, the treatment with SFN alone does no effect the cell cycle progression
(Fig. 2a). We also detected the viability of the cells with SRB assay. As shown in Fig. 3b, hSDF
cells viability decrease significantly with 25µM of H2O2 only while 1µM SNF does not affect it
(Fig. 3b). This data suggests that the cells receive a damage at higher concentration of hydrogen
peroxide even if this is sublethal and the oxidative status of the cell appears recovered .
To investigate if the treatments affects apoptosis, we detected a well known anti-apoptotic
factors, survivin. Fig.3c shows an increased level of expression of survivin in cells treated with both
concentration of hydrogen peroxide without or in the presence of SNF. Moreover, the treatment
with SNF alone does not affect survivin expression Fig.3c.
Finally, we checked p53, a well known factor which controls the genome by orchestrating a
variety of DNA-damage-response to restore genome stability and that plays a critical role in trig-
gering apoptotic pathways in damaged cells [13]. Interestingly, the treatment with 1µM SNF alone
increases significantly the level of expression of total p53 (Fig. 2d). This effect disappears when
the cells are submitted to both SNF and oxidative stress (Fig. 2d).
Effect of SNF alone or with oxidative stress on gamma-H2AX positive cells
Histone γH2AX is the most sensitive marker of double-stranded DNA breaks (DSB) and telom-
ere shortening [14]. Herein we have quantified the number of foci γ-H2AX positive cells in hSDF
cells after 8 day of oxidative stress induction with or without 1µM SFN. As shown in Fig. 3,
there is a significant increase in the number of γH2AX positive foci increasing the concentration
of hydrogen peroxide. In SNF treated cells there is no significant change in comparison to the
untreated cells( Fig. 3)
SNF contrast the loss of nuclear Lamin B due to H2O2 treatment
The treatment with H2O2 (15 or 25µM) induces a significant decrease of Lamin B without any
significant changes in the level of expression of Lamin A (Fig. 4). Loss of Lamin B has already
been reported in the literature to be associated with the prolongation of S phase and oxidative
stress condition [15, 16]. Interestingly, the treatment with 1µM SNF is able to contrasts this effect
at both concentration of H2O2, leaving Lamin A levels unchanged (Fig. 4).
Discussion
Sulforaphane (SFN) is mainly present in Brassica plants such as broccoli sprouts and cabbages.
It is a very well tolerate factor, showing antioxidant properties and inhibiting histone deacetylase
enzymes (HDAC) [9]. In a recent study, it has been investigated the effect of SNF on human
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mesenchymal stem cells (MSCs) at low or high concentration [17], giving opposite effects. In fact,
while low doses of SNF (1µM) for 3 days enhanced the cellular proliferation and protected the
cells toward apoptosis and senescence, higher concentration (5µM) had a cytotoxic effect, leading
to the induction of cell cycle arrest, programmed cell death and senescence [17]. SNF seems to
have a double face effect: on one side acts as anti-tumorigenic factor targeting cancer stem cells
(CSC) [18] and on the other hand helps the clearance of progerin in accelerating ageing [19].
The main two goals of this paper were to investigate the effect of sublethal concentration and
long-term exposure with SFN on human normal cells (hSDF) on critical functions of the cells and
the possible protective role of SFN. Our experimental approach leads to faithfully mimic physi-
ologic conditions allowing the cells to recover possible damages. In fact, in most of the studies
reported in the literature, the experimental induction of oxidative stress condition is achieved by
short exposure of the cells to high concentration of exogenous ROS, or by long and continuous
exposure to moderate concentration of exogenous ROS. Both of these models are unlikely to repro-
duce physiologic conditions, where stimuli are discontinuous and ROS exposure limited. Indeed,
excluding particular pathological conditions, it is very rare to find, a prolonged increase of ROS
levels but rather occasional and short increase of ROS levels, albeit for a long time.
It is known that sublethal concentration of ROS acts mainly as second messengers in signaling
cascade and it is involved in cell proliferation and differentiation [20]. The sublethal exposure
repeated for 30 min every 48 h up to 8 days does not change the oxidative status of the cell measured
as levels of ROS, the number of mitochondria and levels of reduced thiols in total proteins. This
suggest that the cells under this treatment can compensate and recover the oxidative status. In
this connection, higher concentration (90-360 µM) has been reported to increase the number of
mitochondria in fibroblasts [21].
However, hydrogen peroxide alone or in combination with SNF, modify the complex and delicate
physiology of the cells since they starting to promote the cell cycle, to contrast apoptosis increasing
survivin without any significant changes in p53. Lamin B is also affected.
This picture is consistent with the presence of higher number of foci gamma H2AX positive
DNA damage detected in hydrogen peroxide treated cells. Two interesting results are related to
SNF. Firstly, SNF induces alone an increase of p53 and itself does not induce any DNA damage,
playing a protective role. Consistently, it is known that p53 by SNF can promote the stabiliza-
tion of p53 oscillatory behavior [22],[23]. Moreover, p53 prevents the accumulation of oxidative
damage in cells and thus maintain genomic stability by direct transcriptional regulation of genes
involved in oxidative-stress responses or modulating other pathways important in oxidative-stress
responses[24]. The second interesting resulkt is that SNF can not contrast the effect of hydroen
peroxide in hSDF cells. On the other hand, higher levels of SNF (higher than 5mM ) was shown
to induce apoptosis via an incraese of ROS[25]
Methods
Cell lines and treatments
Human primary dermal fibroblasts (hSDF) were obtained as previously described by [26] and
cultured in EMEM (Euroclone) containing 1% L-Glutamine, 1% Penicillin/Streptomycin and 10%
FBS (basal medium) at 37◦C in 5% CO2 for no more than 10 passages[26]. The cells are treated
at sublethal concentration of H2O2 for short (30min) and repeated time according to [3].
Briefly, subconfluent cells were plated and exposed to 15 or 25µM H2O2 (Fluka cod.95302) for
30 minutes at 37◦C, this treatment was repeated every 48 h for four times Fig. S1. Untreated
cells were plated and grown in basal medium for all the time of the experiment (8 days) Fig. S1.
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After every treatment with H2O2, the cells were washed twice with sterile PBS and maintained
in basal medium until the other treatment. Subconfluent cells were treated with sulforaphane
(SNF, cod.S4441, Sigma) at a final concentration of 1µM for 8 days after plating (see Fig. S1).
In combined experiments with H2O2 and SNF, the cells were maintained with H2O2 for 30min
without SNF, then replaced with fresh medium containing SNF Fig. S1.
Cell proliferation assay by SRB
Sulforhodamine B (SRB) assay allow to quantify cellular protein content according to (Sul-
forhodamine B (SRB) Assay in Cell Culture to Investigate Cell Proliferation 2017). Briefly, the
cells were fixed with 10% Trichloroacetic acid (Sigma, cod.T6399 ) for 2 hours at 4◦C and 0.04%
(wt/vol) SRB protein-bound dye (Sulforhodamine B Sigma, cod. S1402, dissolved in 10 mMTris
base solution) was added to each well and incubated at RT for 1hour. After four washes with 1%
(vol/vol) acetic acid, the samples were left to air-dry at room temperature. 100µl of 10 mM Tris
base solution (pH 10.5) was added to each well and shake the plate on an orbital shaker for 10 min
to solubilize the protein-bound dye. The absorbance at 510nm was detected using an microplate
reader (BioRad) at 510nm.
Cell Cycle Analysis
Subconfluent cells were harvested by trypsinization, pelleted and fixed in 70% cold ethanol
and subsequently stained with propidium iodide (PI, cod. P4864, Sigma) for 30 minutes at 4◦C.
PI fluorescence was analyzed using FACS Vantage SE Becton Dickinson flow cytometry. The
percentages of cells in each phase of the cell cycle were calculated using FlowJO software.
p53 level of expression by flow cytometry
Subconfluent cells were fixed 15 minutes in methanol at -20◦C, and than incubated with primary
antibody p53 linked to FITC at 4◦C (1:500, Abcam, ab156030) for 1h and then immediately
analysed using FACS Vantage SE Becton Dickinson flow cytometry. Analysis were conducted
using FlowJo software and the expression of p53 for each sample is reported as the ratio between
the intensity of fluorescence with respect to unstained cells due to autofluorescence.
Quantification of intracellular ROS by H2DCFDA
To detect ROS in cells, the cell-permeant 2’,7’-dichlorodihydrofluorescein diacetate (H2DCFDA)(Thermo
Fisher, cod.D399) has been used. The latter is converted into the highly fluorescent 2’,7’-dichlorofluorescein
(DCF) by the cleavage of acetate groups due to intracellular esterases and oxidation. Briefly, acety-
lated dyes has been reconstituted in anhydrous dimethylsulfoxide (DMSO) at stock concentration
of 100µM just prior to use. Cells have been incubated in 10µM dye solution in pre-warmed PBS
for 1h at 37◦C in 5% CO2, protected from light. Following, loading buffer has been removed and
cells returned to prewarmed growth medium and incubate at the optimal temperature, for 1h
at 37◦C in 5% CO2 in order to allow esterases to hydrolyze the acetate groups and render the
dye responsive to oxidation. Fluorescence has been determined using Ensight microplate fluores-
cence reader (Perkin Elmer) using and Ex/Em: 492495/517527nm. Results are reported as mean
fluoresce values for each sample.
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goat-serum/0.3% glycine/0.1% Tween in PBS) for 1h at RT. The cells were incubated overnight at
4◦C with the primary antibody as following:Lamin A ( 1:100, Abcam ab8980), Lamin B1 (1:200,
Abcam ab16048), γH2AX (1:700, Abcam, ab2893-Phosho139), anti-survivin (1:250, NB500-201,
Novus Biological). The samples were incubated with secondary antibodies FITC anti-Rabbit
(1:250, ab150077, AbCam) or anti-Mouse (1:250, MAP501F, Millipore) for 1h at RT and then
mounted with Pro-long anti-fade reagent (P7481, Life Technologies) with DAPI to stain the nu-
clei. The images were acquired with a Leica TCS NT confocal microscope.
0.1. γH2AX spots counting
γH2AX spots inside the nuclei were counted using spot detector tool of ICY Software as de-
scribed in our previous paper [27]. Briefly, we computed the intensity of the marker used to spot
the damage inside the nuclei. After the treatment we created a script with Matlab which was able
to quantify the intensity of every pixel and to divide the intensities into a bin according to the
scale. All the nuclei taken into account were split from the original images and elaborated (this
to reduce the noise of non-specific signal). The script uses the imhist function to quantify all the
pixels and divide them into a range 255 bin wide. To plot the value we chose a semi-logarithmic
scale plot. All the resulting values are normalized with the total number of pixels of their image,
to make possible the comparison of all the nuclei, one with each other.
62
Figures
0
200
400
600
800
MITOCHONDRIA AMOUNT
S
ta
in
ed
/u
ns
ta
in
ed
ce
lls
ra
tio
CT
RL 15 25 SN
F
15
+S
NF
25
+S
NF
0
1000
2000
3000
4000
ROS AMOUNT
Av
er
ag
e 
D
C
F 
flu
or
es
ce
nc
e 
in
te
ns
ity
1 CTRL
2 SNF
3 15
4 25
5 15 + SNF
6 25 + SNF
 
1 2 3 4 5 6
a) b)
c)
CT
RL 15 25 SN
F
15
+S
NF
25
+S
NF
Figure 1: Evaluation of oxidative status after treatment with sublethal concentration, short and
repeated exposure with hydrogen peroxide without or with 1µM SNF a) ROS detection. Subconfluent
cells treated as described in Fig. S1 and Material and Methods section, are incubated in 10µM H2DCFDA (Thermo
Fisher, cod.D399) in pre-warmed PBS for 1h at 37◦C in 5% CO2. Fluorescence has been determined using Ensight
microplate fluorescence reader (Perkin Elmer) using and Ex/Em: 492495/517527nm. Results are reported as mean
fluoresce values for each sample. b) Number of Mitochondria. Cells treated as described in (a) are quantified using
MitoTracker probe, which passively diffuses across the plasma membrane and accumulates in active mitochondria.
Subconfluent cells were incubated with 250nM MitoTracker (Thermo Fisher, cod. M7512) for 45min at 37◦C in
5% CO2. Fluorescence has been detected using FACS Vantage SE Becton Dickinson flow cytometry and the data
were analyzed by FlowJo. Results are reported as the ratio between the intensity of fluorescence of each sample
with respect to unstained cells due to autofluorescence. c) Reduced thiols into total protein. Total cellular proteins
were obtained by cell homogenization with ice-cold lysis buffer. The lysate was incubated on ice for 30 min and
centrifuged at 10000rpm, for 10 min at 4◦C to remove cell debris. The concentration of protein was assessed using
BCA protein assay. To detect thiols present into proteins a biotin-maleimide assay was carried out. 1mg/mL
of protein was incubated with 75µM biotin-maleimide solution for 1 hour at RT and then mixed to Laemmli
sample buffer, boiled for 5 min at 90◦C and immediately loaded on 12% SDSPAGE gel. The protein were then
electroblotted onto a low-fluorescence polyvinylidene difluoride (LF-PVDF) membrane. Biotin tag was revealed
using streptavidin-HRP assay. Biotinylated proteins were visualized by ECL detection (cod.1705061, Biorad) using
Chemidoc Touch Imaging System (Biorad). ECL signals has been normalized with respect to PVDF stain free.
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Figure 2: Effect on cell vitality, cell cycle and survivin expression after the treatment after the treat-
ment with sublethal concentration, short and repeated exposure with hydrogen peroxide without or
with 1µM SNF. a) Sulforhodamine B (SRB) assay. Briefly, cells (see Fig. S1) were fixed with 10% Trichloroacetic
acid (Sigma, cod.T6399 ) for 2 hours at 4◦C. 0.04% (wt/vol) SRB protein-bound dye was added to each well and
incubated at RT for 1hour. 100µl of 10 mM Tris base solution (pH 10.5) was added to each well and the plate
placed on an orbital shaker for 10 min to solubilize the protein-bound dye. The absorbance was detected using
a Ensight microplate reader (Perkin Elmer) at 510nm. (b) Cell cycle. Subconfluent cells were fixed in 70% cold
ethanol and stained with propidium iodide (PI, cod. P4864, Sigma) for 30 minutes at 4◦C. PI fluorescence was
analyzed using FACS Vantage SE Becton Dickinson flow cytometry. The percentages of cells in each phase of the
cell cycle were calculated using FlowJO software. (c) Immunofluorescence on survivin. Subconfuent cells plated
on coverslips were fixed with 3.7% paraformaldehyde, permeabilized with 0.1%TRITOX-100 in PBS for 15min at
RT, and incubated overnight at 4◦C with anti-survivin (1:250, NB500-201, Novus Biological). The samples were
incubated with secondary antibodies FITC anti-Rabbit (1:250, ab150077, AbCam) and then mounted with Pro-long
anti-fade reagent (P7481, Life Technologies) with DAPI to stain the nuclei. The images were acquired with a Leica
TCS NT confocal microscope. d) Quantification of p53 by flow cytometry. Subconfluent cells were fixed 15 minutes
in ice cold methanol at -20◦C, and then incubated with primary antibody anti-p53 FITC-conjugated at 4◦C (1:500,
Abcam, ab156030 Mouse) for 1h and then immediately analysed using FACS Vantage SE Becton Dickinson flow
cytometry. Analysis were conducted using FlowJo software and the expression of p53 for each sample is reported
as the ratio between the intensity of fluorescence with respect to unstained cells due to autofluorescence.
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Figure 3: Effects of SFN alone or in combination with oxidative stress on DNA-damage a) Subconfuent
cells plated on coverslips were fixed with 3.7% paraformaldehyd, permeabilized with 0.1%TRITOX-100 in PBS for
15min at RT and incubated with incubated overnight at 4◦C with the γH2AX (1:700, Abcam, ab2893-Phosho139),
The samples were then incubated with FITC anti-Rabbit (1:250, ab150077, AbCam) for 1h at RT and then mounted
with Pro-long anti-fade reagent (P7481, Life Technologies) with DAPI to stain the nuclei. The images were acquired
with a Leica TCS NT confocal microscope. γH2AX spots inside the nuclei were counted using spot detector tool
of ICY Software as described in the Materials and Method section All the resulting values are normalized with the
total number of pixels of their image, to make possible the comparison of all the nuclei, one with each other.
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Figure 4: Effect of short and repeated sublethal treatment with H2O2 and 1µM SNF alone or in combination on the
level of expression of Lamin A and B. Panel a. 15µg protein were loaded on 12% SDS-PAGE gel and transferred
on PVDF using the TranBlot Turbo Transfer System Bio-Rad. The membrane was incubated overnight at 4◦C
with primary antibodies: anti- Lamin B1 (Abcam ab16048 1:1.000 Rabbit) or anti-Lamin A (Abcam, ab8980 Mouse
1:1000 ) and then with secondary antibody (anti-Mouse HRP (Bio-Rad 1: 3000) for 1h. ECL Blotting reagents were
used at room temperature to detect chemioluminescence. The signal has been acquired using Chemidoc Touch.
Panels b,c. Densitometric analysis was performed with ImageJ.
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Concluding remarks and future
perspectives
The research reported in this thesis is the results of 3 years of works spent investigating differ-
ent aspects of Nuclear lamina biology. Taking into consideration Hutchinson-Guilford Progeria
Syndrome as an extreme example of what nuclear lamina aberration entails, we studied the
effect of nuclear lamina alteration on global gene expression regulation, on cell mechanics, and
the interconnection existing between nuclear lamina integrity, ageing and oxidative stress. In
Chapter 1, we performed a bioinformatics study to study the impact of Lamin A mutation
on global gene expression regulation, in HGPS patients. We analysed all the public available
transcriptomic data sets of HGPS and compared them with those of healthy matched controls.
Once identified genes that are differentially expressed in the analysed groups, we identified the
pathways in which genes differentially expressed in HGPS patients are involved using pathway
deregulation score analysis. This kind of analysis shows a clear impairment of Epithelial to
Mesenchymal Transition (EMT) pathway in HGPS subjects. EMT is a physiologic process
during which epithelial cell undergo to a phenotypic switching that involved the loss of cell
polarity and cell-to-cell adhesion but also the gain of migratory and invasive properties, typical
of mesenchymal stem cells. EMT impairment, reported by our study, is in agreement with the
hypothesis of a stem cells exhaustion in these patients or mesenchymal lineage differentiation
defects. Given all the obtained results, we can conclude that mutation in Lamin A gene strongly
impact on global gene expression regulation. Chapter 2 deals with the investigation of how nu-
clear lamina alterations impact on its physical and functional connections with extra-nuclear
and nuclear elements. To do this, we developed an inducible cellular model of the mutated form
of Lamin A responsible for HGPS. Our model faithfully resembles the typical HGPS-patients’
nuclear phenotype. Our results clearly show that Progerin presence makes cell nucleus stiffer
and less plastic. Furthermore, our data revealed that Progerin expression induces modifications
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of the complex interactions present between nuclear lamina and the cytoskeleton. These mainly
consist in the establishment of a stronger and more stable coupling between nucleus and cy-
toskeleton. Nevertheless, we also investigated whether Progerin expression somehow influences
the physiologic interaction occurring between nuclear lamina and PcGs protein, components
of Polycomb Repressor Complexes 1 and 2. These are key epigenetic regulators of the chro-
matin status that in physiologic conditions directly bind to wild type Lamin A. We found that
Progerin expression significantly interferes in Lamin A-PRC2 interactions, opening up new pos-
sible scenarios to further investigate. Physiological ageing and HGPS share some clinical and
biological features, among which nuclear shape defects and deterioration, proliferation impair-
ment, progerin and reactive oxygen species accumulation. Moreover, expression and stability
of lamins proteins are altered in response to oxidative stress, that is in turn strongly linked to
ageing process and the consequent nuclear morphology alterations. Finally, in Chapter 3 we
investigated the interdependence between ROS, ageing and lamins in a novel oxidative stress
cellular model developed in our laboratory, that is also efficient in recapitulating typical ageing
profile. Our findings revealed, that oxidative stress impacts differently on Lamin A and Lamina
B1: while it has no effects on Lamin A expression, it induces a significant Lamin B loss which
can be rescued by anti-oxidant supplementation. Overall, this study contributes to shed light
on the role of the nuclear lamina in health and disease providing new insight but also opening
up to new scenarios that need to be further investigated. In the future, indeed, it would be of
great interest to study deeper the functional effect of the reduced interaction between wild type
Lamin A and PCR2 observed in presence of Progerin, since this could be linked to heterochro-
matin loss in HGPS. Intriguingly, the latter is another common feature between Progeria and
normal aging. Our group is now going on to study lamins focusing on the impact of progerin in
tumor cells. In fact, it has been reported that in tumor cells progerin is expressed and we are
now investigating the impact of this aberrant lamin in the contest of a tumor cell instead of a
normal cell like happens in HGPS.
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